{"parse":{"title":"Pharming (genetics)","pageid":1749134,"revid":853691567,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">For pharming on the <a href=\"/wiki/Internet\" title=\"Internet\">Internet</a>, see <a href=\"/wiki/Pharming\" title=\"Pharming\">Pharming</a>. For pharming in drug abuse, see <a href=\"/wiki/Pharming_parties\" class=\"mw-redirect\" title=\"Pharming parties\">Pharming parties</a>.</div>\n<p><b>Pharming</b>, a <a href=\"/wiki/Portmanteau\" title=\"Portmanteau\">portmanteau</a> of \"farming\" and \"<a href=\"/wiki/Pharmaceutical\" class=\"mw-redirect\" title=\"Pharmaceutical\">pharmaceutical</a>\", refers to the use of <a href=\"/wiki/Genetic_engineering\" title=\"Genetic engineering\">genetic engineering</a> to insert <a href=\"/wiki/Gene\" title=\"Gene\">genes</a> that code for useful pharmaceuticals into host animals or plants that would otherwise not express those genes, thus creating a <a href=\"/wiki/Genetically_modified_organism\" title=\"Genetically modified organism\">genetically modified organism</a> (GMO).<sup id=\"cite_ref-worldwide_1-0\" class=\"reference\"><a href=\"#cite_note-worldwide-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-library_2-0\" class=\"reference\"><a href=\"#cite_note-library-2\">&#91;2&#93;</a></sup> Pharming is also known as <b>molecular farming</b>, <b>molecular pharming</b><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> or <b>biopharming</b>.<sup id=\"cite_ref-miller2003_4-0\" class=\"reference\"><a href=\"#cite_note-miller2003-4\">&#91;4&#93;</a></sup>\n</p><p>The products of pharming are recombinant proteins or their metabolic products.  Recombinant proteins are most commonly produced using <a href=\"/wiki/Bacteria\" title=\"Bacteria\">bacteria</a> or <a href=\"/wiki/Yeast\" title=\"Yeast\">yeast</a> in a <a href=\"/wiki/Bioreactor\" title=\"Bioreactor\">bioreactor</a>, but pharming offers the advantage to the producer that it does not require expensive infrastructure, and production capacity can be quickly scaled to meet demand, at greatly reduced cost.<sup id=\"cite_ref-Kaiser_5-0\" class=\"reference\"><a href=\"#cite_note-Kaiser-5\">&#91;5&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#In_mammals\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">In mammals</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Historical_development\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Historical development</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Patentability_issues\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Patentability issues</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#In_plants\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">In plants</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Regulation\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Regulation</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Controversy\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Controversy</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Advantages\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Advantages</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Disadvantages\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Disadvantages</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#List_of_originators_(companies_and_universities),_research_projects_and_products\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">List of originators (companies and universities), research projects and products</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#See_also\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#Further_reading\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-14\"><a href=\"#External_links\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The first <a href=\"/wiki/Recombinant_DNA\" title=\"Recombinant DNA\">recombinant</a> plant-derived protein (PDP) was human <a href=\"/wiki/Serum_albumin\" title=\"Serum albumin\">serum albumin</a>, initially produced in 1990 in transgenic <a href=\"/wiki/Tobacco\" title=\"Tobacco\">tobacco</a> and <a href=\"/wiki/Potato\" title=\"Potato\">potato</a> plants.<sup id=\"cite_ref-sijmons_6-0\" class=\"reference\"><a href=\"#cite_note-sijmons-6\">&#91;6&#93;</a></sup>  Open field growing trials of these crops began in the United States in 1992 and have taken place every year since.  While the <a href=\"/wiki/United_States_Department_of_Agriculture\" title=\"United States Department of Agriculture\">United States Department of Agriculture</a> has approved planting of pharma crops in every state, most testing has taken place in Hawaii, Nebraska, Iowa, and Wisconsin.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p><p>In the early 2000s, the pharming industry was robust.  Proof of concept has been established for the production of many <a href=\"/wiki/Protein-protein_interaction\" class=\"mw-redirect\" title=\"Protein-protein interaction\">therapeutic proteins</a>, including <a href=\"/wiki/Antibodies\" class=\"mw-redirect\" title=\"Antibodies\">antibodies</a>, <a href=\"/wiki/Blood_products\" class=\"mw-redirect\" title=\"Blood products\">blood products</a>, <a href=\"/wiki/Cytokines\" class=\"mw-redirect\" title=\"Cytokines\">cytokines</a>, <a href=\"/wiki/Growth_factors\" class=\"mw-redirect\" title=\"Growth factors\">growth factors</a>, <a href=\"/wiki/Hormones\" class=\"mw-redirect\" title=\"Hormones\">hormones</a>, <a href=\"/wiki/Recombinant_DNA\" title=\"Recombinant DNA\">recombinant enzymes</a> and human and <a href=\"/wiki/Veterinary\" class=\"mw-redirect\" title=\"Veterinary\">veterinary</a> <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a>.<sup id=\"cite_ref-ScienceD_8-0\" class=\"reference\"><a href=\"#cite_note-ScienceD-8\">&#91;8&#93;</a></sup>  By 2003 several PDP products for the treatment of <a href=\"/wiki/Human_diseases\" class=\"mw-redirect\" title=\"Human diseases\">human diseases</a> were under development by nearly 200 biotech companies, including <a href=\"/wiki/Recombinant_DNA\" title=\"Recombinant DNA\">recombinant</a> <a href=\"/wiki/Gastric_lipase\" title=\"Gastric lipase\">gastric lipase</a> for the treatment of <a href=\"/wiki/Cystic_fibrosis\" title=\"Cystic fibrosis\">cystic fibrosis</a>, and <a href=\"/wiki/Antibodies\" class=\"mw-redirect\" title=\"Antibodies\">antibodies</a> for the prevention of <a href=\"/wiki/Dental_caries\" class=\"mw-redirect\" title=\"Dental caries\">dental caries</a> and the treatment of <a href=\"/wiki/Non-Hodgkin%27s_lymphoma\" class=\"mw-redirect\" title=\"Non-Hodgkin&#39;s lymphoma\">non-Hodgkin's lymphoma</a>.<sup id=\"cite_ref-christou_9-0\" class=\"reference\"><a href=\"#cite_note-christou-9\">&#91;9&#93;</a></sup>\n</p><p>Several proteins were brought to market as research and bioproduction reagents, mostly by <a href=\"/wiki/Sigma-Aldrich\" title=\"Sigma-Aldrich\">Sigma-Aldrich</a>.  ProdiGene struck agreements with Sigma to distribute ProdiGene's corn-produced aprotinin, trypsin,<sup id=\"cite_ref-SigmaDetailSheet_10-0\" class=\"reference\"><a href=\"#cite_note-SigmaDetailSheet-10\">&#91;10&#93;</a></sup> beta-glucuronidase (GUS), and avidin.  Large Scale Biology and SIgma agreed that Sigma would distribute LSBC's tobacco-produced aprotinin.  Sigma also agreed to distribute Ventria's rise-produced Lactoferrin and Lysozyme.\n</p><p>However, in late 2002, just as ProdiGene was ramping up production of trypsin for commercial launch<sup id=\"cite_ref-Press_Release_on_Trypsin_scale-up_11-0\" class=\"reference\"><a href=\"#cite_note-Press_Release_on_Trypsin_scale-up-11\">&#91;11&#93;</a></sup> it was discovered that volunteer plants (left over from the prior harvest) of one of their GM corn products were harvested with the conventional soybean crop later planted in that field.<sup id=\"cite_ref-News_of_contamination_12-0\" class=\"reference\"><a href=\"#cite_note-News_of_contamination-12\">&#91;12&#93;</a></sup>  ProdiGene was fined $250,000 and ordered by the USDA to pay over $3 million in cleanup costs.  This raised a furor and set the pharming field back, dramatically.<sup id=\"cite_ref-Kaiser_5-1\" class=\"reference\"><a href=\"#cite_note-Kaiser-5\">&#91;5&#93;</a></sup> Many companies went bankrupt as companies faced difficulties getting permits for field trials and investors fled.<sup id=\"cite_ref-Kaiser_5-2\" class=\"reference\"><a href=\"#cite_note-Kaiser-5\">&#91;5&#93;</a></sup>  In reaction, APHIS introduced more strict regulations for pharming field trials in the US in 2003.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>  In 2005, <a href=\"/wiki/Anheuser-Busch\" title=\"Anheuser-Busch\">Anheuser-Busch</a> threatened to boycott rice grown in Missouri because of plans by <a href=\"/wiki/Ventria_Bioscience\" title=\"Ventria Bioscience\">Ventria Bioscience</a> to grow pharm rice in the state.  A compromise was reached, but Ventria withdrew its permit to plant in Missouri due to unrelated circumstances.\n</p><p>The industry has slowly recovered, by focusing on pharming in simple plants grown in <a href=\"/wiki/Bioreactors\" class=\"mw-redirect\" title=\"Bioreactors\">bioreactors</a> and on growing GM crops in greenhouses.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> Some companies and academic groups have continued with open-field trials of GM crops that produce drugs.  In 2006 <a href=\"/wiki/Dow_AgroSciences\" title=\"Dow AgroSciences\">Dow AgroSciences</a> received USDA approval to market a vaccine for poultry against <a href=\"/wiki/Newcastle_disease\" title=\"Newcastle disease\">Newcastle disease</a>, produced in plant cell culture \u2013 the first plant-produced vaccine approved in the U.S.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-nature_16-0\" class=\"reference\"><a href=\"#cite_note-nature-16\">&#91;16&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"In_mammals\">In mammals</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=2\" title=\"Edit section: In mammals\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Historical_development\">Historical development</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=3\" title=\"Edit section: Historical development\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Milk is presently the most mature system to produce recombinant proteins from transgenic organisms. Blood, egg white, <a href=\"/w/index.php?title=Seminal_plasma&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Seminal plasma (page does not exist)\">seminal plasma</a>, and urine are other theoretically possible systems, but all have drawbacks. Blood, for instance, as of 2012 cannot store high levels of stable recombinant proteins, and biologically active proteins in blood may alter the health of the animals.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>  Expression in the  milk of a mammal, such as a cow, sheep, or goat, is a common application, as milk production is plentiful and purification from milk is relatively easy.  Hamsters and rabbits have also been used in preliminary studies because of their faster breeding.\n</p><p>One  approach to this technology is the creation of a transgenic mammal that can produce the biopharmaceutical in its milk (or blood or urine). Once an animal is produced, typically using the pronuclear microinjection method, it becomes efficacious to use cloning technology to create additional offspring that carry the favorable modified genome.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>  In February 2009 the US FDA granted marketing approval for the first drug to be produced in genetically modified livestock.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> The drug is called <a href=\"/wiki/ATryn\" title=\"ATryn\">ATryn</a>, which is antithrombin protein purified from the milk of genetically modified <a href=\"/wiki/Goats\" class=\"mw-redirect\" title=\"Goats\">goats</a>.  Marketing permission was granted by the <a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a> in August 2006.<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Patentability_issues\">Patentability issues</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=4\" title=\"Edit section: Patentability issues\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>As indicated above, some mammals typically used for food production (such as goats, sheep, pigs, and cows) have been modified to produce non-food products, a practice sometimes called pharming. Use of genetically modified goats has been approved by the FDA and EMA to produce <a href=\"/wiki/ATryn\" title=\"ATryn\">ATryn</a>, i.e. recombinant <a href=\"/wiki/Antithrombin\" title=\"Antithrombin\">antithrombin</a>, an <a href=\"/wiki/Anticoagulant\" title=\"Anticoagulant\">anticoagulant</a> <a href=\"/wiki/Biologic_medical_product\" class=\"mw-redirect\" title=\"Biologic medical product\">protein drug</a>.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup> These products \"produced by turning animals into drug-manufacturing 'machines' by genetically modifying them\" are sometimes termed <a href=\"/wiki/Biopharmaceuticals\" class=\"mw-redirect\" title=\"Biopharmaceuticals\">biopharmaceuticals</a>.\n</p><p>The patentability of such biopharmaceuticals and their process of manufacture is uncertain. Probably, the biopharmaceuticals themselves so made are unpatentable, assuming that they are chemically identical to the preexisting drugs that they imitate. Several 19th century <a href=\"/wiki/United_States_Supreme_Court\" class=\"mw-redirect\" title=\"United States Supreme Court\">United States Supreme Court</a> decisions hold that a previously known natural product manufactured by artificial means cannot be patented.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> An argument can be made for the patentability of the process for manufacturing a biopharmaceutical, however, because genetically modifying animals so that they will produce the drug is dissimilar to previous methods of manufacture; moreover, one Supreme Court decision seems to hold open that possibility.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>\n</p><p>On the other hand, it has been suggested that the recent Supreme Court decision in <i><a href=\"/wiki/Mayo_v._Prometheus\" class=\"mw-redirect\" title=\"Mayo v. Prometheus\">Mayo v. Prometheus</a></i><sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> may create a problem in that, in accordance with the ruling in that case, \"it may be said that such and such genes manufacture this protein in the same way they always did in a mammal, they produce the same product, and the genetic modification technology used is conventional, so that the steps of the process 'add nothing to the laws of nature that is not already present.<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> If the argument prevailed in court, the process would also be ineligible for patent protection. This issue has not yet been decided in the courts.\n</p>\n<h2><span class=\"mw-headline\" id=\"In_plants\">In plants</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=5\" title=\"Edit section: In plants\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Plant-made pharmaceuticals (PMPs), also referred to as pharming, is a sub-sector of the <a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">biotechnology</a> industry that involves the process of genetically engineering plants so that they can produce certain types of therapeutically important <a href=\"/wiki/Proteins\" class=\"mw-redirect\" title=\"Proteins\">proteins</a> and associated molecules such as peptides and secondary metabolites.  The proteins and molecules can then be harvested and used to produce pharmaceuticals.\n</p><p>Recently, several non-crop plants such as the <a href=\"/wiki/Lemna\" title=\"Lemna\">duckweed</a> <i><a href=\"/wiki/Lemna_minor\" title=\"Lemna minor\">Lemna minor</a></i> or the <a href=\"/wiki/Moss\" title=\"Moss\">moss</a> <i><a href=\"/wiki/Physcomitrella_patens\" title=\"Physcomitrella patens\">Physcomitrella patens</a></i> have shown to be useful for the production of biopharmaceuticals. These frugal organisms can be cultivated in <a href=\"/wiki/Bioreactors\" class=\"mw-redirect\" title=\"Bioreactors\">bioreactors</a> (as opposed to being grown in fields), secrete the transformed proteins into the growth medium and, thus, substantially reduce the burden of <a href=\"/wiki/Protein_purification\" title=\"Protein purification\">protein purification</a> in preparing recombinant proteins for medical use.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup>  In addition, both species can be engineered to cause secretion of proteins with human patterns of <a href=\"/wiki/Glycosylation\" title=\"Glycosylation\">glycosylation</a>, an improvement over conventional plant gene-expression systems.<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup><sup id=\"cite_ref-Decker_(2008)_30-0\" class=\"reference\"><a href=\"#cite_note-Decker_(2008)-30\">&#91;30&#93;</a></sup> <a href=\"/wiki/Biolex\" title=\"Biolex\">Biolex</a> Therapeutics developed a duckweed-based expression platform; it sold that business to <a href=\"/wiki/Synthon_(company)\" title=\"Synthon (company)\">Synthon</a> and declared bankruptcy in 2012.\n</p><p>Additionally, an Israeli company, Protalix, has developed a method to produce therapeutics in cultured transgenic carrot or tobacco cells.<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>  Protalix and its partner, Pfizer, received FDA approval to market its drug, <a href=\"/wiki/Taliglucerase_alfa\" title=\"Taliglucerase alfa\">taliglucerase alfa</a> (Elelyso), treatment for <a href=\"/wiki/Gaucher%27s_disease\" title=\"Gaucher&#39;s disease\">Gaucher's disease</a>, in 2012.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup>\n</p><p><a href=\"/wiki/Arabidopsis_thaliana\" title=\"Arabidopsis thaliana\">Arabidopsis</a> is often used as a <a href=\"/wiki/Model_organism\" title=\"Model organism\">model organism</a> to study gene expression in plants, while actual production may be carried out in <a href=\"/wiki/Maize\" title=\"Maize\">maize</a>, <a href=\"/wiki/Rice\" title=\"Rice\">rice</a>, <a href=\"/wiki/Potatoes\" class=\"mw-redirect\" title=\"Potatoes\">potatoes</a>, <a href=\"/wiki/Tobacco\" title=\"Tobacco\">tobacco</a>, <a href=\"/wiki/Flax\" title=\"Flax\">flax</a> or <a href=\"/wiki/Safflower\" title=\"Safflower\">safflower</a>.  The advantage of rice and flax is that they are self-pollinating, and thus <a href=\"/wiki/Gene_flow\" title=\"Gene flow\">gene flow</a> issues (see below) are avoided.  However, human error could still result in pharm crops entering the food supply.  Using a minor crop such as safflower or tobacco, avoids the greater political pressures and risk to the food supply involved with using staple crops such as beans or rice.\n</p>\n<h2><span class=\"mw-headline\" id=\"Regulation\">Regulation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=6\" title=\"Edit section: Regulation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Regulation_of_the_release_of_genetic_modified_organisms\" class=\"mw-redirect\" title=\"Regulation of the release of genetic modified organisms\">Regulation of the release of genetic modified organisms</a></div>\n<p>The regulation of genetic engineering concerns the approaches taken by governments to assess and manage the risks associated with the development and release of genetically modified crops. There are differences in the regulation of GM crops \u2013 including those used for pharming \u2013 between countries, with some of the most marked differences occurring between the USA and Europe. Regulation varies in a given country depending on the intended use of the products of the genetic engineering. For example, a crop not intended for food use is generally not reviewed by authorities responsible for food safety.\n</p>\n<h2><span class=\"mw-headline\" id=\"Controversy\">Controversy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=7\" title=\"Edit section: Controversy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Genetically_modified_food_controversies\" title=\"Genetically modified food controversies\">Genetically modified food controversies</a></div>\n<p>There are controversies around GMOs generally on several levels, including whether making them is ethical, issues concerning intellectual property and market dynamics; environmental effects of GM crops; and GM crops' role in industrial agricultural more generally.  There are also specific controversies around pharming.\n</p>\n<h3><span class=\"mw-headline\" id=\"Advantages\">Advantages</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=8\" title=\"Edit section: Advantages\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Plants\" class=\"mw-redirect\" title=\"Plants\">Plants</a> do not carry <a href=\"/wiki/Pathogens\" class=\"mw-redirect\" title=\"Pathogens\">pathogens</a> that might be dangerous to human <a href=\"/wiki/Health\" title=\"Health\">health</a>. Additionally, on the level of <a href=\"/wiki/Pharmacologically\" class=\"mw-redirect\" title=\"Pharmacologically\">pharmacologically</a> active <a href=\"/wiki/Protein\" title=\"Protein\">proteins</a>, there are no proteins in plants that are similar to human proteins. On the other hand, plants are still sufficiently closely related to animals and humans that they are able to correctly process and configure both animal and human proteins. Their seeds and fruits also provide sterile packaging containers for the valuable therapeutics and guarantee a certain storage life.<sup id=\"cite_ref-BioPro_33-0\" class=\"reference\"><a href=\"#cite_note-BioPro-33\">&#91;33&#93;</a></sup>\n</p><p><a href=\"/wiki/Supply_and_demand\" title=\"Supply and demand\">Global demand</a> for <a href=\"/wiki/Pharmaceuticals\" class=\"mw-redirect\" title=\"Pharmaceuticals\">pharmaceuticals</a> is at unprecedented levels.  Expanding the existing <a href=\"/wiki/Microbial\" class=\"mw-redirect\" title=\"Microbial\">microbial</a> systems, although feasible for some therapeutic products, is not a satisfactory option on several grounds.<sup id=\"cite_ref-ScienceD_8-1\" class=\"reference\"><a href=\"#cite_note-ScienceD-8\">&#91;8&#93;</a></sup>  Many proteins of interest are too complex to be made by microbial systems or by <a href=\"/wiki/Protein_synthesis\" class=\"mw-redirect\" title=\"Protein synthesis\">protein synthesis</a>.<sup id=\"cite_ref-sijmons_6-1\" class=\"reference\"><a href=\"#cite_note-sijmons-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-BioPro_33-1\" class=\"reference\"><a href=\"#cite_note-BioPro-33\">&#91;33&#93;</a></sup> These proteins are currently being produced in animal <a href=\"/wiki/Cell_culture\" title=\"Cell culture\">cell cultures</a>, but the resulting product is often prohibitively expensive for many patients.  For these reasons, science has been exploring other options for producing proteins of therapeutic value.<sup id=\"cite_ref-library_2-1\" class=\"reference\"><a href=\"#cite_note-library-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-ScienceD_8-2\" class=\"reference\"><a href=\"#cite_note-ScienceD-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-nature_16-1\" class=\"reference\"><a href=\"#cite_note-nature-16\">&#91;16&#93;</a></sup>\n</p><p>These pharmaceutical crops could become extremely beneficial in developing countries.  The <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> estimates that nearly 3 million people die each year from vaccine preventable disease, mostly in Africa.  Diseases such as measles and hepatitis lead to deaths in countries where the people cannot afford the high costs of vaccines, but pharm crops could help solve this problem.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Disadvantages\">Disadvantages</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=9\" title=\"Edit section: Disadvantages\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>While molecular farming is one application of <a href=\"/wiki/Genetic_engineering\" title=\"Genetic engineering\">genetic engineering</a>, there are concerns that are unique to it. In the case of <a href=\"/wiki/Genetically_modified\" class=\"mw-redirect\" title=\"Genetically modified\">genetically modified</a> (GM) foods, concerns focus on the safety of the food for <a href=\"/wiki/Ingestion\" title=\"Ingestion\">human consumption</a>. In response, it has been argued that the genes that enhance a <a href=\"/wiki/Crop\" title=\"Crop\">crop</a> in some way, such as <a href=\"/wiki/Drought_resistance\" class=\"mw-redirect\" title=\"Drought resistance\">drought resistance</a> or <a href=\"/wiki/Pesticide_resistance\" title=\"Pesticide resistance\">pesticide resistance</a>, are not believed to affect the food itself. Other GM foods in development, such as fruits designed to ripen faster or grow larger, are believed not to affect humans any differently from non-GM varieties.<sup id=\"cite_ref-library_2-2\" class=\"reference\"><a href=\"#cite_note-library-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-nature_16-2\" class=\"reference\"><a href=\"#cite_note-nature-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-BioPro_33-2\" class=\"reference\"><a href=\"#cite_note-BioPro-33\">&#91;33&#93;</a></sup><sup id=\"cite_ref-wired_35-0\" class=\"reference\"><a href=\"#cite_note-wired-35\">&#91;35&#93;</a></sup>\n</p><p>In contrast, molecular farming is not intended for crops destined for the <a href=\"/wiki/Food_chain\" title=\"Food chain\">food chain</a>. It produces plants that contain <a href=\"/wiki/Physiology\" title=\"Physiology\">physiologically</a> active compounds that accumulate in the plant\u2019s tissues. Considerable attention is focused, therefore, on the restraint and caution necessary to protect both consumer health and environmental <a href=\"/wiki/Biodiversity\" title=\"Biodiversity\">biodiversity</a>.<sup id=\"cite_ref-library_2-3\" class=\"reference\"><a href=\"#cite_note-library-2\">&#91;2&#93;</a></sup>\n</p><p>The fact that the plants are used to produce drugs alarms <a href=\"/wiki/Activists\" class=\"mw-redirect\" title=\"Activists\">activists</a>. They worry that once production begins, the altered plants might find their way into the food supply or <a href=\"/wiki/Pollination\" title=\"Pollination\">cross-pollinate</a> with conventional, non-GM crops.<sup id=\"cite_ref-wired_35-1\" class=\"reference\"><a href=\"#cite_note-wired-35\">&#91;35&#93;</a></sup>  These concerns have historical validation from the ProdiGene incident, and from the <a href=\"/wiki/Transgenic_maize\" class=\"mw-redirect\" title=\"Transgenic maize\">StarLink</a> incident, in which <a href=\"/wiki/Genetically_Modified\" class=\"mw-redirect\" title=\"Genetically Modified\">GMO</a> corn accidentally ended up in commercial food products.  Activists also are concerned about the power of business. According to the <a href=\"/wiki/Canadian_Food_Inspection_Agency\" title=\"Canadian Food Inspection Agency\">Canadian Food Inspection Agency</a>, in a recent report, says that U.S. demand alone for biotech pharmaceuticals is expanding at 13 percent annually and to reach a market value of $28.6 billion in 2004.<sup id=\"cite_ref-wired_35-2\" class=\"reference\"><a href=\"#cite_note-wired-35\">&#91;35&#93;</a></sup> Pharming is expected to be worth $100 billion globally by 2020.<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p>\n<h2><span id=\"List_of_originators_.28companies_and_universities.29.2C_research_projects_and_products\"></span><span class=\"mw-headline\" id=\"List_of_originators_(companies_and_universities),_research_projects_and_products\">List of originators (companies and universities), research projects and products</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=10\" title=\"Edit section: List of originators (companies and universities), research projects and products\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><i>Please note that this list is by no means exhaustive.</i>\n</p>\n<ul><li><a href=\"/wiki/Dow_AgroSciences\" title=\"Dow AgroSciences\">Dow AgroSciences</a> \u2013 poultry vaccine against <a href=\"/wiki/Newcastle_disease_virus\" class=\"mw-redirect\" title=\"Newcastle disease virus\">Newcastle disease virus</a> (first PMP to be approved for marketing by the <a href=\"/wiki/USDA\" class=\"mw-redirect\" title=\"USDA\">USDA</a> Center for Veterinary Biologics<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup> Dow never intended to market the vaccine.<sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup> \"'Dow Agrosciences used the animal vaccine as an example to completely run through the process. A new platform needs to be approved, which can be difficult when authorities get in contact with it for the first time', explains the plant physiologist Stefan Schillberg, head of the Molecular Biology Division at the Fraunhofer Institute for Molecular Biology and Applied Ecology Aachen.\"<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup></li>\n<li><a href=\"/wiki/Fraunhofer_Society\" title=\"Fraunhofer Society\">Fraunhofer</a> Institute for Molecular Biology and Applied Ecology, with sites in Germany, the US, and Chile<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup> is the lead institute of the Pharma Planta consortium of 33 partner organizations from 12 European countries and South Africa, funded by the European Commission.<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup>  Pharma Planta is developing systems for plant production of proteins in greenhouses in the European regulatory framework.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> It is collaborating on biosimilars with Plantform and PharmaPraxis (see below).<sup id=\"cite_ref-Brennan_43-0\" class=\"reference\"><a href=\"#cite_note-Brennan-43\">&#91;43&#93;</a></sup></li>\n<li><a href=\"/wiki/Genzyme\" title=\"Genzyme\">Genzyme</a> \u2013 <a href=\"/wiki/Antithrombin_III\" class=\"mw-redirect\" title=\"Antithrombin III\">antithrombin III</a> in goat milk</li>\n<li>GTC Biotherapeutics \u2013 <a href=\"/wiki/ATryn\" title=\"ATryn\">ATryn</a> (recombinant human antithrombin) in goat milk<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup></li>\n<li>Icon Genetics produces therapeutics in transiently infected <i>Nicotiana benthamiana</i> (relative of tobacco) plants in greenhouses in Halle, Germany<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup><sup id=\"cite_ref-NHL-Launch_46-0\" class=\"reference\"><a href=\"#cite_note-NHL-Launch-46\">&#91;46&#93;</a></sup> or in fields. First product is a vaccine for a cancer, <a href=\"/wiki/Non-Hodgkin%27s_lymphoma\" class=\"mw-redirect\" title=\"Non-Hodgkin&#39;s lymphoma\">non-Hodgkin's lymphoma</a>.<sup id=\"cite_ref-NHL-Launch_46-1\" class=\"reference\"><a href=\"#cite_note-NHL-Launch-46\">&#91;46&#93;</a></sup></li>\n<li>Iowa State University \u2013 immunogenic protein from <i><a href=\"/wiki/Escherichia_coli\" title=\"Escherichia coli\">E. coli</a></i> bacteria in pollen-free corn as a potential vaccine against <i>E. coli</i> for animals and humans<sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup><sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup><sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup></li>\n<li>Kentucky Bioprocessing took over Large Scale Biology's facilities in Owensboro, Kentucky, and offers contract biomanufacturing services in tobacco plants, grown in greenhouses or in open fields.<sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup></li>\n<li><a href=\"/w/index.php?title=Medicago_(company)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Medicago (company) (page does not exist)\">Medicago Inc.</a> \u2013 Pre-clinical trials of <a href=\"/wiki/Influenza_vaccine\" title=\"Influenza vaccine\">Influenza vaccine</a> made in transiently infected <i>Nicotiana benthamiana</i> (relative of tobacco) plants in greenhouses<sup id=\"cite_ref-51\" class=\"reference\"><a href=\"#cite_note-51\">&#91;51&#93;</a></sup>   Medicago has a system for pharming in <a href=\"/wiki/Alfalfa\" title=\"Alfalfa\">alfalfa</a> that their website says is \"not suited for the production of vaccines\"<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup></li>\n<li>PharmaPraxis \u2013 Developing biosimilars in collaboration with PlantForm (see below) and <a href=\"/wiki/Fraunhofer_Society\" title=\"Fraunhofer Society\">Fraunhofer</a>.<sup id=\"cite_ref-Brennan_43-1\" class=\"reference\"><a href=\"#cite_note-Brennan-43\">&#91;43&#93;</a></sup></li>\n<li>Pharming \u2013 <a href=\"/wiki/C1_inhibitor\" class=\"mw-redirect\" title=\"C1 inhibitor\">C1 inhibitor</a>, human <a href=\"/wiki/Collagen\" title=\"Collagen\">collagen</a> 1, <a href=\"/wiki/Fibrinogen\" title=\"Fibrinogen\">fibrinogen</a> (with <a href=\"/wiki/American_Red_Cross\" title=\"American Red Cross\">American Red Cross</a>), and <a href=\"/wiki/Lactoferrin\" title=\"Lactoferrin\">lactoferrin</a> in cow milk<sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup>  The intellectual property behind the fibrinogen project was acquired from PPL Therapeutics when PPL went bankrupt in 2004.<sup id=\"cite_ref-PPL-Press_54-0\" class=\"reference\"><a href=\"#cite_note-PPL-Press-54\">&#91;54&#93;</a></sup></li>\n<li>Phyton Biotech uses plant cell culture systems to manufacture <a href=\"/wiki/Active_pharmaceutical_ingredients\" class=\"mw-redirect\" title=\"Active pharmaceutical ingredients\">active pharmaceutical ingredients</a> based on <a href=\"/wiki/Taxanes\" class=\"mw-redirect\" title=\"Taxanes\">taxanes</a>, including <a href=\"/wiki/Paclitaxel\" title=\"Paclitaxel\">paclitaxel</a> and <a href=\"/wiki/Docetaxel\" title=\"Docetaxel\">docetaxel</a><sup id=\"cite_ref-55\" class=\"reference\"><a href=\"#cite_note-55\">&#91;55&#93;</a></sup></li>\n<li>Planet Biotechnology \u2013 <a href=\"/wiki/Antibodies\" class=\"mw-redirect\" title=\"Antibodies\">antibodies</a> against <a href=\"/wiki/Streptococcus_mutans\" title=\"Streptococcus mutans\">Streptococcus mutans</a>, antibodies against <a href=\"/wiki/Doxorubicin\" title=\"Doxorubicin\">doxorubicin</a>, and <a href=\"/wiki/Intercellular_adhesion_molecule\" title=\"Intercellular adhesion molecule\">ICAM 1</a> <a href=\"/wiki/Receptor_(biochemistry)\" title=\"Receptor (biochemistry)\">receptor</a> in tobacco<sup id=\"cite_ref-56\" class=\"reference\"><a href=\"#cite_note-56\">&#91;56&#93;</a></sup></li>\n<li>PlantForm Corporation \u2013 <a href=\"/wiki/Biosimilar\" title=\"Biosimilar\">biosimilar</a> <a href=\"/wiki/Trastuzumab\" title=\"Trastuzumab\">trastuzumab</a> in tobacco<sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup> \u2013 It is developing biosimilars in collaboration with  PharmaPraxis (see above) and <a href=\"/wiki/Fraunhofer_Society\" title=\"Fraunhofer Society\">Fraunhofer</a>.<sup id=\"cite_ref-Brennan_43-2\" class=\"reference\"><a href=\"#cite_note-Brennan-43\">&#91;43&#93;</a></sup></li>\n<li>ProdiGene \u2013 was developing several proteins, including <a href=\"/wiki/Aprotinin\" title=\"Aprotinin\">aprotinin</a>, <a href=\"/wiki/Trypsin\" title=\"Trypsin\">trypsin</a> and a veterinary <a href=\"/wiki/Gastroenteritis\" title=\"Gastroenteritis\">TGE</a> vaccine in corn.  Was in process of launching trypsin product in 2002<sup id=\"cite_ref-Press_Release_on_Trypsin_scale-up_11-1\" class=\"reference\"><a href=\"#cite_note-Press_Release_on_Trypsin_scale-up-11\">&#91;11&#93;</a></sup> when later that year its field test crops contaminated conventional crops.<sup id=\"cite_ref-News_of_contamination_12-1\" class=\"reference\"><a href=\"#cite_note-News_of_contamination-12\">&#91;12&#93;</a></sup>  Unable to pay the $3 million cost of the cleanup, it was purchased by International Oilseed Distributors in 2003<sup id=\"cite_ref-58\" class=\"reference\"><a href=\"#cite_note-58\">&#91;58&#93;</a></sup><sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup>  International Oilseed Distributors is controlled by Harry H. Stine,<sup id=\"cite_ref-60\" class=\"reference\"><a href=\"#cite_note-60\">&#91;60&#93;</a></sup> who owns one of the biggest soybeans genetics companies in the US.<sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup>  ProdiGene's maize-produced trypsin, with the trademark TrypZean<sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup> is currently sold by Sigma-Aldritch as a research reagent.<sup id=\"cite_ref-SigmaDetailSheet_10-1\" class=\"reference\"><a href=\"#cite_note-SigmaDetailSheet-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-63\" class=\"reference\"><a href=\"#cite_note-63\">&#91;63&#93;</a></sup><sup id=\"cite_ref-64\" class=\"reference\"><a href=\"#cite_note-64\">&#91;64&#93;</a></sup></li>\n<li><a href=\"/wiki/Syngenta\" title=\"Syngenta\">Syngenta</a> \u2013 <a href=\"/wiki/Beta_carotene\" class=\"mw-redirect\" title=\"Beta carotene\">Beta carotene</a> in rice (this is \"<a href=\"/wiki/Golden_rice\" title=\"Golden rice\">Golden rice</a> 2\"), which Syngenta has donated to the Golden Rice Project<sup id=\"cite_ref-65\" class=\"reference\"><a href=\"#cite_note-65\">&#91;65&#93;</a></sup></li>\n<li>University of Arizona \u2013 <a href=\"/wiki/Hepatitis_C\" title=\"Hepatitis C\">Hepatitis C</a> vaccine in potatoes<sup id=\"cite_ref-66\" class=\"reference\"><a href=\"#cite_note-66\">&#91;66&#93;</a></sup><sup id=\"cite_ref-67\" class=\"reference\"><a href=\"#cite_note-67\">&#91;67&#93;</a></sup></li>\n<li><a href=\"/wiki/Ventria_Bioscience\" title=\"Ventria Bioscience\">Ventria Bioscience</a> \u2013 <a href=\"/wiki/Lactoferrin\" title=\"Lactoferrin\">lactoferrin</a> and <a href=\"/wiki/Lysozyme\" title=\"Lysozyme\">lysozyme</a> in rice</li>\n<li>Washington State University \u2013 <a href=\"/wiki/Lactoferrin\" title=\"Lactoferrin\">lactoferrin</a> and <a href=\"/wiki/Lysozyme\" title=\"Lysozyme\">lysozyme</a> in barley<sup id=\"cite_ref-68\" class=\"reference\"><a href=\"#cite_note-68\">&#91;68&#93;</a></sup><sup id=\"cite_ref-69\" class=\"reference\"><a href=\"#cite_note-69\">&#91;69&#93;</a></sup></li>\n<li>European <a href=\"/wiki/COST\" class=\"mw-redirect\" title=\"COST\">COST</a> Action on Molecular Farming \u2013 COST Action FA0804 on Molecular Farming provides a pan-European coordination centre, connecting academic and government institutions and companies from 23 countries.<sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup> The aim of the Action is to advance the field by encouraging scientific interactions, providing expert opinion and encouraging commercial development of new products. The COST Action also provides grants allowing young scientists to visit participating laboratories across Europe for scientific training.</li>\n<li><a href=\"/wiki/Mapp_Biopharmaceutical\" title=\"Mapp Biopharmaceutical\">Mapp Biopharmaceutical</a> in <a href=\"/wiki/San_Diego,_California\" class=\"mw-redirect\" title=\"San Diego, California\">San Diego, California</a>, was reported in August 2014 to be developing <a href=\"/wiki/ZMapp\" title=\"ZMapp\">ZMapp</a>, an experimental cure for the deadly <a href=\"/wiki/Ebola_virus_disease\" title=\"Ebola virus disease\">Ebola virus disease</a>. Two Americans who had been infected in Liberia were reported to be improving with the drug. ZMapp was made using antibodies produced by GM tobacco plants.<sup id=\"cite_ref-71\" class=\"reference\"><a href=\"#cite_note-71\">&#91;71&#93;</a></sup><sup id=\"cite_ref-72\" class=\"reference\"><a href=\"#cite_note-72\">&#91;72&#93;</a></sup></li></ul>\n<p><b>Projects known to be abandoned</b>\n</p>\n<ul><li>Agragen, in collaboration with University of Alberta \u2013 <a href=\"/wiki/Docosahexaenoic_acid\" title=\"Docosahexaenoic acid\">docosahexaenoic acid</a> and <a href=\"/wiki/Human_serum_albumin\" title=\"Human serum albumin\">human serum albumin</a> in <a href=\"/wiki/Flax\" title=\"Flax\">flax</a><sup id=\"cite_ref-73\" class=\"reference\"><a href=\"#cite_note-73\">&#91;73&#93;</a></sup><sup id=\"cite_ref-74\" class=\"reference\"><a href=\"#cite_note-74\">&#91;74&#93;</a></sup><sup id=\"cite_ref-75\" class=\"reference\"><a href=\"#cite_note-75\">&#91;75&#93;</a></sup></li>\n<li>Chlorogen, Inc. \u2013  <a href=\"/wiki/Cholera\" title=\"Cholera\">cholera</a>, <a href=\"/wiki/Anthrax\" title=\"Anthrax\">anthrax</a>, and <a href=\"/wiki/Bubonic_plague\" title=\"Bubonic plague\">plague</a> <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a>,  albumin, <a href=\"/wiki/Interferon\" title=\"Interferon\">interferon</a> for liver diseases including <a href=\"/wiki/Hepatitis_C\" title=\"Hepatitis C\">hepatitis C</a>, <a href=\"/wiki/Elastin\" title=\"Elastin\">elastin</a>, 4HB, and <a href=\"/wiki/Insulin-like_growth_factor\" title=\"Insulin-like growth factor\">insulin-like growth factor</a> in <a href=\"/wiki/Tobacco\" title=\"Tobacco\">tobacco</a> <a href=\"/wiki/Chloroplasts\" class=\"mw-redirect\" title=\"Chloroplasts\">chloroplasts</a>.  Went out of business in 2007.<sup id=\"cite_ref-76\" class=\"reference\"><a href=\"#cite_note-76\">&#91;76&#93;</a></sup></li>\n<li><a href=\"/wiki/Dow_Chemical_Company\" title=\"Dow Chemical Company\">Dow Chemical Company</a> made a deal with Sunol Molecular in 2003 to develop antibodies against tissue factor in plants and in mammalian cell culture and to compare them.<sup id=\"cite_ref-77\" class=\"reference\"><a href=\"#cite_note-77\">&#91;77&#93;</a></sup>  In 2005 Sunol sold all its tissue factor antagonists to <a href=\"/wiki/Tanox\" title=\"Tanox\">Tanox</a>,<sup id=\"cite_ref-78\" class=\"reference\"><a href=\"#cite_note-78\">&#91;78&#93;</a></sup><sup id=\"cite_ref-79\" class=\"reference\"><a href=\"#cite_note-79\">&#91;79&#93;</a></sup> which in turn was bought by <a href=\"/wiki/Genentech\" title=\"Genentech\">Genentech</a> in 2003.  Genentech licensed the tissue factor program to Altor in 2008<sup id=\"cite_ref-80\" class=\"reference\"><a href=\"#cite_note-80\">&#91;80&#93;</a></sup>  Altor is itself a spinout from Sunol.<sup id=\"cite_ref-81\" class=\"reference\"><a href=\"#cite_note-81\">&#91;81&#93;</a></sup>  The product under development, ALT-836, formerly known as TNX-832 and Sunol-cH36,<sup id=\"cite_ref-82\" class=\"reference\"><a href=\"#cite_note-82\">&#91;82&#93;</a></sup> is not the plant-produced antibody, but rather is mammalian antibody, more specifically, a chimeric antibody produced in a hybridoma.<sup id=\"cite_ref-83\" class=\"reference\"><a href=\"#cite_note-83\">&#91;83&#93;</a></sup></li>\n<li><a href=\"/wiki/Epicyte\" class=\"mw-redirect\" title=\"Epicyte\">Epicyte</a> \u2013 spermicidal antibodies in corn<sup id=\"cite_ref-84\" class=\"reference\"><a href=\"#cite_note-84\">&#91;84&#93;</a></sup>  Epicyte was purchased by <a href=\"/wiki/Biolex\" title=\"Biolex\">Biolex</a> in 2004 at which time Epicyte's portfolio was described as \"focused on the discovery and development of human monoclonal antibody products as treatments for a wide range of infectious and inflammatory diseases.\"<sup id=\"cite_ref-85\" class=\"reference\"><a href=\"#cite_note-85\">&#91;85&#93;</a></sup></li>\n<li>Large Scale Biology Corporation (LSBC) (<i>bankrupt</i>)<sup id=\"cite_ref-86\" class=\"reference\"><a href=\"#cite_note-86\">&#91;86&#93;</a></sup> \u2013 used <a href=\"/wiki/Tobacco_mosaic_virus\" title=\"Tobacco mosaic virus\">Tobacco mosaic virus</a> to develop reagents and patient-specific vaccines for <a href=\"/wiki/Non-Hodgkin%27s_lymphoma\" class=\"mw-redirect\" title=\"Non-Hodgkin&#39;s lymphoma\">Non-Hodgkin's lymphoma</a>, <a href=\"/wiki/Papillomavirus\" class=\"mw-redirect\" title=\"Papillomavirus\">Papillomavirus</a> vaccine, <a href=\"/wiki/Parvovirus\" title=\"Parvovirus\">parvovirus</a> vaccine, <a href=\"/wiki/Alpha_galactosidase\" class=\"mw-redirect\" title=\"Alpha galactosidase\">alpha galactosidase</a> for <a href=\"/wiki/Fabry_disease\" title=\"Fabry disease\">Fabry disease</a>, <a href=\"/wiki/Lysosomal_lipase\" title=\"Lysosomal lipase\">lysosomal acid lipase</a>, <a href=\"/wiki/Aprotinin\" title=\"Aprotinin\">aprotinin</a>, <a href=\"/wiki/Interferon\" title=\"Interferon\">interferon</a> Alpha 2a and 2b, <a href=\"/wiki/G-CSF\" class=\"mw-redirect\" title=\"G-CSF\">G-CSF</a>, and <a href=\"/wiki/Hepatitis_B\" title=\"Hepatitis B\">Hepatitis B</a> vaccine antigens in tobacco.  In 2004, LSBC announced an agreement with Sigma-Aldritch under which LSB would produce recombinant aprotinin in plants of the tobacco family and Sigma-Aldrich would commercially distribute LSBC's recombinant product to its customers in the R&amp;D, cell culture and manufacturing markets.<sup id=\"cite_ref-87\" class=\"reference\"><a href=\"#cite_note-87\">&#91;87&#93;</a></sup>  As of October 2012 SIgma still has the protein in stock.<sup id=\"cite_ref-88\" class=\"reference\"><a href=\"#cite_note-88\">&#91;88&#93;</a></sup></li>\n<li>Meristem Therapeutics \u2013 <a href=\"/wiki/Lipase\" title=\"Lipase\">Lipase</a>, <a href=\"/wiki/Lactoferrin\" title=\"Lactoferrin\">lactoferrin</a>, plasma proteins, <a href=\"/wiki/Collagen\" title=\"Collagen\">collagen</a>, <a href=\"/wiki/Antibodies\" class=\"mw-redirect\" title=\"Antibodies\">antibodies</a> (IgA, IgM), <a href=\"/wiki/Allergens\" class=\"mw-redirect\" title=\"Allergens\">allergens</a> and <a href=\"/wiki/Protease_inhibitors\" class=\"mw-redirect\" title=\"Protease inhibitors\">protease inhibitors</a> in tobacco.  Liquidated in 2008.<sup id=\"cite_ref-89\" class=\"reference\"><a href=\"#cite_note-89\">&#91;89&#93;</a></sup></li>\n<li>Novoplant GmgH \u2013 therapeutic proteins in tobacco and feed peas.<sup id=\"cite_ref-90\" class=\"reference\"><a href=\"#cite_note-90\">&#91;90&#93;</a></sup>  Conducted field trials in US of feed peas for pigs that produced anti-bacterial antibodies.<sup id=\"cite_ref-91\" class=\"reference\"><a href=\"#cite_note-91\">&#91;91&#93;</a></sup>  Former CSO is now with another company;<sup id=\"cite_ref-92\" class=\"reference\"><a href=\"#cite_note-92\">&#91;92&#93;</a></sup> appears that Novoplant is out of business.</li>\n<li><a href=\"/wiki/Monsanto_Company\" class=\"mw-redirect\" title=\"Monsanto Company\">Monsanto Company</a> \u2013 abandoned development of pharmaceutical producing corn</li>\n<li>PPL Therapeutics \u2013 <a href=\"/wiki/Alpha_1-antitrypsin\" class=\"mw-redirect\" title=\"Alpha 1-antitrypsin\">Alpha 1-antitrypsin</a> for <a href=\"/wiki/Cystic_fibrosis\" title=\"Cystic fibrosis\">cystic fibrosis</a> and <a href=\"/wiki/Emphysema\" class=\"mw-redirect\" title=\"Emphysema\">emphysema</a> in <a href=\"/wiki/Sheep_milk\" title=\"Sheep milk\">sheep milk</a>.  This is the company that created <a href=\"/wiki/Dolly_(sheep)\" title=\"Dolly (sheep)\">Dolly the Sheep</a>, the first cloned animal.  Went bankrupt in 2004. Assets were acquired by Pharming<sup id=\"cite_ref-PPL-Press_54-1\" class=\"reference\"><a href=\"#cite_note-PPL-Press-54\">&#91;54&#93;</a></sup> and an investment group including University of Pittsburgh Medical Center.<sup id=\"cite_ref-93\" class=\"reference\"><a href=\"#cite_note-93\">&#91;93&#93;</a></sup></li>\n<li><a href=\"/wiki/SemBioSys_Genetics_Inc._(Calgary)\" class=\"mw-redirect\" title=\"SemBioSys Genetics Inc. (Calgary)\">SemBioSys</a> \u2013 <a href=\"/wiki/Insulin\" title=\"Insulin\">insulin</a> in safflower.  In May 2012, SemBioSys terminated its operations.<sup id=\"cite_ref-BankruptcyAnnouncement_94-0\" class=\"reference\"><a href=\"#cite_note-BankruptcyAnnouncement-94\">&#91;94&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=11\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Biopharmaceutical\" title=\"Biopharmaceutical\">Biopharmaceutical</a></li>\n<li><a href=\"/wiki/Bioremediation\" title=\"Bioremediation\">Bioremediation</a></li>\n<li><a href=\"/wiki/Genetically_modified_organism\" title=\"Genetically modified organism\">Genetically modified organism</a></li>\n<li><a href=\"/wiki/Polly_and_Molly\" title=\"Polly and Molly\">Polly and Molly</a></li>\n<li><a href=\"/wiki/International_Center_for_Technology_Assessment\" title=\"International Center for Technology Assessment\">International Center for Technology Assessment</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=12\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-worldwide-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-worldwide_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a href=\"/wiki/Michael_Quinion\" title=\"Michael Quinion\">Quinion, Michael</a>. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.worldwidewords.org/turnsofphrase/tp-mol2.htm\">\"Molecular farming\"</a>. <i><a href=\"/wiki/World_Wide_Words\" class=\"mw-redirect\" title=\"World Wide Words\">World Wide Words</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-09-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Wide+Words&amp;rft.atitle=Molecular+farming&amp;rft.au=Quinion%2C+Michael&amp;rft_id=http%3A%2F%2Fwww.worldwidewords.org%2Fturnsofphrase%2Ftp-mol2.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-library-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-library_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-library_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-library_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-library_2-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Norris, Sonya (4 July 2005). <a rel=\"nofollow\" class=\"external text\" href=\"http://www2.parl.gc.ca/Content/LOP/ResearchPublications/prb0509-e.htm\">\"Molecular farming\"</a>. <i><a href=\"/wiki/Library_of_Parliament\" title=\"Library of Parliament\">Library of Parliament</a></i>. <a href=\"/wiki/Parliament_of_Canada\" title=\"Parliament of Canada\">Parliament of Canada</a>. PRB 05-09E<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-09-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Library+of+Parliament&amp;rft.atitle=Molecular+farming&amp;rft.date=2005-07-04&amp;rft.au=Norris%2C+Sonya&amp;rft_id=http%3A%2F%2Fwww2.parl.gc.ca%2FContent%2FLOP%2FResearchPublications%2Fprb0509-e.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Humphreys, John M; Chapple, Clint (2000). \"Molecular 'pharming' with plant P450s\". <i><a href=\"/wiki/Trends_Plant_Sci.\" class=\"mw-redirect\" title=\"Trends Plant Sci.\">Trends Plant Sci.</a></i> <b>5</b> (7): 271\u20132. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1360-1385%2800%2901680-0\">10.1016/S1360-1385(00)01680-0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10871897\">10871897</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+Plant+Sci.&amp;rft.atitle=Molecular+%27pharming%27+with+plant+P450s&amp;rft.volume=5&amp;rft.issue=7&amp;rft.pages=271-2&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1016%2FS1360-1385%2800%2901680-0&amp;rft_id=info%3Apmid%2F10871897&amp;rft.aulast=Humphreys&amp;rft.aufirst=John+M&amp;rft.au=Chapple%2C+Clint&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Paywall\" title=\"closed access publication \u2013 behind paywall\"><img alt=\"closed access publication \u2013 behind paywall\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/9px-Closed_Access_logo_alternative.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/14px-Closed_Access_logo_alternative.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/18px-Closed_Access_logo_alternative.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></span>\n</li>\n<li id=\"cite_note-miller2003-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-miller2003_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\"><a href=\"/wiki/Henry_I._Miller\" title=\"Henry I. Miller\">Miller, Henry I.</a> (2003). \"Will we reap what biopharming sows?\". Commentary. <i><a href=\"/wiki/Nat._Biotechnol.\" class=\"mw-redirect\" title=\"Nat. Biotechnol.\">Nat. Biotechnol.</a></i> <b>21</b> (5): 480\u20131. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nbt0503-480\">10.1038/nbt0503-480</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12721561\">12721561</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Biotechnol.&amp;rft.atitle=Will+we+reap+what+biopharming+sows%3F&amp;rft.volume=21&amp;rft.issue=5&amp;rft.pages=480-1&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt0503-480&amp;rft_id=info%3Apmid%2F12721561&amp;rft.aulast=Miller&amp;rft.aufirst=Henry+I.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Paywall\" title=\"closed access publication \u2013 behind paywall\"><img alt=\"closed access publication \u2013 behind paywall\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/9px-Closed_Access_logo_alternative.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/14px-Closed_Access_logo_alternative.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/18px-Closed_Access_logo_alternative.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></span>\n</li>\n<li id=\"cite_note-Kaiser-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Kaiser_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Kaiser_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Kaiser_5-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kaiser, Jocelyn (25 April 2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://people.forestry.oregonstate.edu/steve-strauss/sites/people.forestry.oregonstate.edu.steve-strauss/files/Is%20drought%20over%20for%20pharming%20Science%202007.pdf\">\"Is the Drought Over for Pharming?\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i><a href=\"/wiki/Science_(journal)\" title=\"Science (journal)\">Science</a></i>. <b>320</b> (5875): 473&#8211;5. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.320.5875.473\">10.1126/science.320.5875.473</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18436771\">18436771</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Is+the+Drought+Over+for+Pharming%3F&amp;rft.volume=320&amp;rft.issue=5875&amp;rft.pages=473-5&amp;rft.date=2008-04-25&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.320.5875.473&amp;rft_id=info%3Apmid%2F18436771&amp;rft.au=Kaiser%2C+Jocelyn&amp;rft_id=http%3A%2F%2Fpeople.forestry.oregonstate.edu%2Fsteve-strauss%2Fsites%2Fpeople.forestry.oregonstate.edu.steve-strauss%2Ffiles%2FIs%2520drought%2520over%2520for%2520pharming%2520Science%25202007.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-sijmons-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-sijmons_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-sijmons_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sijmons, Peter C.; Dekker, Ben M. M.; Schrammeijer, Barbara;  et al. (1990). \"Production of Correctly Processed Human Serum Albumin in Transgenic Plants\". <i><a href=\"/wiki/Bio/Technology\" class=\"mw-redirect\" title=\"Bio/Technology\">Bio/Technology</a></i>. <b>8</b> (3): 217\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nbt0390-217\">10.1038/nbt0390-217</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1366404\">1366404</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bio%2FTechnology&amp;rft.atitle=Production+of+Correctly+Processed+Human+Serum+Albumin+in+Transgenic+Plants&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=217-21&amp;rft.date=1990&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt0390-217&amp;rft_id=info%3Apmid%2F1366404&amp;rft.aulast=Sijmons&amp;rft.aufirst=Peter+C.&amp;rft.au=Dekker%2C+Ben+M.+M.&amp;rft.au=Schrammeijer%2C+Barbara&amp;rft.au=Verwoerd%2C+Theo+C.&amp;rft.au=Van+Den+Elzen%2C+Peter+J.+M.&amp;rft.au=Hoekema%2C+Andr%C3%A9&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Paywall\" title=\"closed access publication \u2013 behind paywall\"><img alt=\"closed access publication \u2013 behind paywall\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/9px-Closed_Access_logo_alternative.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/14px-Closed_Access_logo_alternative.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/18px-Closed_Access_logo_alternative.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Kimbrell, Andrew (2007). <i>Your right to know: Genetic engineering and the secret change in your food</i>. California: Earth Aware Editions. <a href=\"/wiki/OCLC\" title=\"OCLC\">OCLC</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/oclc/74353733\">74353733</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Your+right+to+know%3A+Genetic+engineering+and+the+secret+change+in+your+food&amp;rft.place=California&amp;rft.pub=Earth+Aware+Editions&amp;rft.date=2007&amp;rft_id=info%3Aoclcnum%2F74353733&amp;rft.aulast=Kimbrell&amp;rft.aufirst=Andrew&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\"><span title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (March 2013)\">page&#160;needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-ScienceD-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ScienceD_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ScienceD_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ScienceD_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Twyman, Richard M.; Stoger, Eva; Schillberg, Stefan;  et al. (2003). \"Molecular farming in plants: Host systems and expression technology\". <i><a href=\"/wiki/Trends_Biotechnol.\" class=\"mw-redirect\" title=\"Trends Biotechnol.\">Trends Biotechnol.</a></i> <b>21</b> (12): 570\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.tibtech.2003.10.002\">10.1016/j.tibtech.2003.10.002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14624867\">14624867</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+Biotechnol.&amp;rft.atitle=Molecular+farming+in+plants%3A+Host+systems+and+expression+technology&amp;rft.volume=21&amp;rft.issue=12&amp;rft.pages=570-8&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tibtech.2003.10.002&amp;rft_id=info%3Apmid%2F14624867&amp;rft.aulast=Twyman&amp;rft.aufirst=Richard+M.&amp;rft.au=Stoger%2C+Eva&amp;rft.au=Schillberg%2C+Stefan&amp;rft.au=Christou%2C+Paul&amp;rft.au=Fischer%2C+Rainer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span style=\"position:relative; top: -2px;\"><a href=\"/wiki/Paywall\" title=\"closed access publication \u2013 behind paywall\"><img alt=\"closed access publication \u2013 behind paywall\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/9px-Closed_Access_logo_alternative.svg.png\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/14px-Closed_Access_logo_alternative.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Closed_Access_logo_alternative.svg/18px-Closed_Access_logo_alternative.svg.png 2x\" data-file-width=\"640\" data-file-height=\"1000\" /></a></span></span>\n</li>\n<li id=\"cite_note-christou-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-christou_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ma, Julian K-C.; Drake, Pascal M. W.; Christou, Paul (2003). \"Genetic modification: The production of recombinant pharmaceutical proteins in plants\". <i>Nature Reviews Genetics</i>. <b>4</b> (10): 794\u2013805. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrg1177\">10.1038/nrg1177</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14526375\">14526375</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Genetics&amp;rft.atitle=Genetic+modification%3A+The+production+of+recombinant+pharmaceutical+proteins+in+plants&amp;rft.volume=4&amp;rft.issue=10&amp;rft.pages=794-805&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1038%2Fnrg1177&amp;rft_id=info%3Apmid%2F14526375&amp;rft.aulast=Ma&amp;rft.aufirst=Julian+K-C.&amp;rft.au=Drake%2C+Pascal+M.+W.&amp;rft.au=Christou%2C+Paul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SigmaDetailSheet-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SigmaDetailSheet_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SigmaDetailSheet_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/General_Information/cell_culture.Par.0001.File.tmp/cell_culture.pdf\">SIgma Info Sheet</a></span>\n</li>\n<li id=\"cite_note-Press_Release_on_Trypsin_scale-up-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Press_Release_on_Trypsin_scale-up_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Press_Release_on_Trypsin_scale-up_11-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation pressrelease\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.prnewswire.com/news-releases/prodigene-launches-first-large-scale-up-manufacturing-of-recombinant-protein-from-plant-system-75984427.html\">\"ProdiGene Launches First Large Scale-Up Manufacturing of Recombinant Protein From Plant System\"</a> (Press release). ProdiGene. February 13, 2002<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">March 8,</span> 2013</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ProdiGene+Launches+First+Large+Scale-Up+Manufacturing+of+Recombinant+Protein+From+Plant+System&amp;rft.pub=ProdiGene&amp;rft.date=2002-02-13&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fprodigene-launches-first-large-scale-up-manufacturing-of-recombinant-protein-from-plant-system-75984427.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-News_of_contamination-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-News_of_contamination_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-News_of_contamination_12-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ngin.tripod.com/151102a.htm\">News of contamination</a><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (March 2013)\">unreliable source?</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\">Biotechnology Regulatory Services Factsheet [Internet]: US Department of Agriculture; c2006. Available from: <a rel=\"nofollow\" class=\"external free\" href=\"http://www.aphis.usda.gov/publications/biotechnology/content/printable_version/BRS_FS_pharmaceutical_02-06.pdf\">http://www.aphis.usda.gov/publications/biotechnology/content/printable_version/BRS_FS_pharmaceutical_02-06.pdf</a></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Boehm, Robert (2007). \"Bioproduction of Therapeutic Proteins in the 21st Century and the Role of Plants and Plant Cells as Production Platforms\". <i>Annals of the New York Academy of Sciences</i>. <b>1102</b>: 121\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1196/annals.1408.009\">10.1196/annals.1408.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17470916\">17470916</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+the+New+York+Academy+of+Sciences&amp;rft.atitle=Bioproduction+of+Therapeutic+Proteins+in+the+21st+Century+and+the+Role+of+Plants+and+Plant+Cells+as+Production+Platforms&amp;rft.volume=1102&amp;rft.pages=121-34&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1196%2Fannals.1408.009&amp;rft_id=info%3Apmid%2F17470916&amp;rft.aulast=Boehm&amp;rft.aufirst=Robert&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharmexec.com/pharmexec/The-First-Plant-Derived-Vaccine-Approved-for-Chick/ArticleStandard/Article/detail/307471\">FDA Approval News</a></span>\n</li>\n<li id=\"cite_note-nature-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-nature_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-nature_16-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-nature_16-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ma, Julian K -C.; Barros, Eugenia; Bock, Ralph; Christou, Paul; Dale, Philip J.; Dix, Philip J.; Fischer, Rainer; Irwin, Judith;  et al. (2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1369121\">\"Molecular farming for new drugs and vaccines\"</a>. <i>EMBO Reports</i>. <b>6</b> (7): 593\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/sj.embor.7400470\">10.1038/sj.embor.7400470</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1369121\">1369121</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15995674\">15995674</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EMBO+Reports&amp;rft.atitle=Molecular+farming+for+new+drugs+and+vaccines&amp;rft.volume=6&amp;rft.issue=7&amp;rft.pages=593-9&amp;rft.date=2005&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1369121&amp;rft_id=info%3Apmid%2F15995674&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.embor.7400470&amp;rft.aulast=Ma&amp;rft.aufirst=Julian+K+-C.&amp;rft.au=Barros%2C+Eugenia&amp;rft.au=Bock%2C+Ralph&amp;rft.au=Christou%2C+Paul&amp;rft.au=Dale%2C+Philip+J.&amp;rft.au=Dix%2C+Philip+J.&amp;rft.au=Fischer%2C+Rainer&amp;rft.au=Irwin%2C+Judith&amp;rft.au=Mahoney%2C+Richard&amp;rft.au=Pezzotti%2C+M.&amp;rft.au=Schillberg%2C+S.&amp;rft.au=Sparrow%2C+P.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1369121&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Houdebine, Louis-Marie (2009). \"Production of pharmaceutical proteins by transgenic animals\". <i>Comparative Immunology, Microbiology and Infectious Diseases</i>. <b>32</b> (2): 107\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cimid.2007.11.005\">10.1016/j.cimid.2007.11.005</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18243312\">18243312</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Comparative+Immunology%2C+Microbiology+and+Infectious+Diseases&amp;rft.atitle=Production+of+pharmaceutical+proteins+by+transgenic+animals&amp;rft.volume=32&amp;rft.issue=2&amp;rft.pages=107-21&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cimid.2007.11.005&amp;rft_id=info%3Apmid%2F18243312&amp;rft.aulast=Houdebine&amp;rft.aufirst=Louis-Marie&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dove, Alan (2000). \"Milking the genome for profit\". <i>Nature Biotechnology</i>. <b>18</b> (10): 1045\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/80231\">10.1038/80231</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11017040\">11017040</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biotechnology&amp;rft.atitle=Milking+the+genome+for+profit&amp;rft.volume=18&amp;rft.issue=10&amp;rft.pages=1045-8&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1038%2F80231&amp;rft_id=info%3Apmid%2F11017040&amp;rft.aulast=Dove&amp;rft.aufirst=Alan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\">Staff (2008) <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/AnimalVeterinary/NewsEvents/FDAVeterinarianNewsletter/ucm190728.htm\">FDA Approves First Human Biologic Produced by GE Animals</a> US Food and Drug Administration, from the FDA Vetenarian Newsletter 2008 Volume XXIII, No VI, Retrieved 10 December 2012</span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://news.bbc.co.uk/1/hi/sci/tech/5041298.stm\">\"Go-ahead for 'pharmed' goat drug\"</a>. <i>BBC News</i>. June 2, 2006<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2006-10-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Go-ahead+for+%27pharmed%27+goat+drug&amp;rft.date=2006-06-02&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F1%2Fhi%2Fsci%2Ftech%2F5041298.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\">Andre Pollack for <i>The New York Times</i>. February 6, 2009 <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2009/02/07/business/07goatdrug.html?pagewanted=all&amp;_r=0\">F.D.A. Approves Drug From Gene-Altered Goats</a></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\">Richard H. Stern. <a rel=\"nofollow\" class=\"external text\" href=\"http://docs.law.gwu.edu/facweb/claw/MayoPro.pdf\"><i>Mayo v Prometheus: No Patents on Conventional Implementations of Natural Principles and Fundamental Truths</i></a>, [2012] Eur. Intell. Prop. Rev. 502, 517. See <i>Cochrane v. Badische Anili11 &amp; Soda Fabrik</i>, 111 U.S. 293, 311 (1884) (holding invalid claim to artificially made plant dye; \"the product itself could not be patented, even though it was a product made artificially for the first time\"); <i>American Wood-Paper Co. v. Fibre Disintegrating Co.</i>, 90 U.S. 566, 596 (1874) (holding invalid claim to artificially manufactured paper-pulp because \"whatever may be said of their process for obtaining it, the product was in no sense new\").</span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\">The <i>American Wood-Paper</i> case invalidated the product patent but left open the patentability of the process, saying \"whatever may be said of their process for obtaining it....\" 90 U.S. at 596.</span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><i>Mayo Collaborative Services v. Prometheus Labs., Inc.</i>, 566 U.S. __, 132 S. Ct. 1289 (2012).</span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\">Richard H. Stern. <a rel=\"nofollow\" class=\"external text\" href=\"http://docs.law.gwu.edu/facweb/claw/MayoPro.pdf\"><i>Mayo v Prometheus: No Patents on Conventional Implementations of Natural Principles and Fundamental Truths</i></a>, [2012] Eur. Intell. Prop. Rev. 502, 517-18 (quoting <i><a href=\"/wiki/Mayo_v._Prometheus\" class=\"mw-redirect\" title=\"Mayo v. Prometheus\">Mayo v. Prometheus</a></i>; see also <i><a href=\"/wiki/Alice_v._CLS_Bank\" class=\"mw-redirect\" title=\"Alice v. CLS Bank\">Alice v. CLS Bank</a></i>, 573 U.S. __, 134 S. Ct. 2347 (2014) (to similar effect).</span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">B\u00fcttner-Mainik, Annette; Parsons, Juliana; J\u00e9r\u00f4me, Hanna; Hartmann, Andrea; Lamer, Stephanie; Schaaf, Andreas; Schlosser, Andreas; Zipfel, Peter F.; Reski, Ralf (2011). \"Production of biologically active recombinant human factor H in Physcomitrella\". <i>Plant Biotechnology Journal</i>. <b>9</b> (3): 373\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1467-7652.2010.00552.x\">10.1111/j.1467-7652.2010.00552.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20723134\">20723134</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Plant+Biotechnology+Journal&amp;rft.atitle=Production+of+biologically+active+recombinant+human+factor+H+in+Physcomitrella&amp;rft.volume=9&amp;rft.issue=3&amp;rft.pages=373-83&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1467-7652.2010.00552.x&amp;rft_id=info%3Apmid%2F20723134&amp;rft.aulast=B%C3%BCttner-Mainik&amp;rft.aufirst=Annette&amp;rft.au=Parsons%2C+Juliana&amp;rft.au=J%C3%A9r%C3%B4me%2C+Hanna&amp;rft.au=Hartmann%2C+Andrea&amp;rft.au=Lamer%2C+Stephanie&amp;rft.au=Schaaf%2C+Andreas&amp;rft.au=Schlosser%2C+Andreas&amp;rft.au=Zipfel%2C+Peter+F.&amp;rft.au=Reski%2C+Ralf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gasdaska, John R.; Spencer, David; Dickey, Lynn (2003). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bioprocessingjournal.com/index.php/article-downloads/329-j22-advantages-of-therapeutic-protein-production-in-the-aquatic-plant-lemna\">\"Advantages of Therapeutic Protein Production in the Aquatic Plant Lemna\"</a>. <i>BioProcessing Journal</i>. <b>2</b> (2): 49\u201356. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.12665/j22.gasdaska\">10.12665/j22.gasdaska</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioProcessing+Journal&amp;rft.atitle=Advantages+of+Therapeutic+Protein+Production+in+the+Aquatic+Plant+Lemna&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=49-56&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.12665%2Fj22.gasdaska&amp;rft.aulast=Gasdaska&amp;rft.aufirst=John+R.&amp;rft.au=Spencer%2C+David&amp;rft.au=Dickey%2C+Lynn&amp;rft_id=http%3A%2F%2Fwww.bioprocessingjournal.com%2Findex.php%2Farticle-downloads%2F329-j22-advantages-of-therapeutic-protein-production-in-the-aquatic-plant-lemna&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Baur, Armin; Reski, Ralf; Gorr, Gilbert (2005). \"Enhanced recovery of a secreted recombinant human growth factor using stabilizing additives and by co-expression of human serum albumin in the moss Physcomitrella patens\". <i>Plant Biotechnology Journal</i>. <b>3</b> (3): 331\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1467-7652.2005.00127.x\">10.1111/j.1467-7652.2005.00127.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17129315\">17129315</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Plant+Biotechnology+Journal&amp;rft.atitle=Enhanced+recovery+of+a+secreted+recombinant+human+growth+factor+using+stabilizing+additives+and+by+co-expression+of+human+serum+albumin+in+the+moss+Physcomitrella+patens&amp;rft.volume=3&amp;rft.issue=3&amp;rft.pages=331-40&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1467-7652.2005.00127.x&amp;rft_id=info%3Apmid%2F17129315&amp;rft.aulast=Baur&amp;rft.aufirst=Armin&amp;rft.au=Reski%2C+Ralf&amp;rft.au=Gorr%2C+Gilbert&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cox, Kevin M; Sterling, Jason D; Regan, Jeffrey T; Gasdaska, John R; Frantz, Karen K; Peele, Charles G; Black, Amelia; Passmore, David; Moldovan-Loomis, Cristina (2006). \"Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor\". <i>Nature Biotechnology</i>. <b>24</b> (12): 1591\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nbt1260\">10.1038/nbt1260</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17128273\">17128273</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biotechnology&amp;rft.atitle=Glycan+optimization+of+a+human+monoclonal+antibody+in+the+aquatic+plant+Lemna+minor&amp;rft.volume=24&amp;rft.issue=12&amp;rft.pages=1591-7&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt1260&amp;rft_id=info%3Apmid%2F17128273&amp;rft.aulast=Cox&amp;rft.aufirst=Kevin+M&amp;rft.au=Sterling%2C+Jason+D&amp;rft.au=Regan%2C+Jeffrey+T&amp;rft.au=Gasdaska%2C+John+R&amp;rft.au=Frantz%2C+Karen+K&amp;rft.au=Peele%2C+Charles+G&amp;rft.au=Black%2C+Amelia&amp;rft.au=Passmore%2C+David&amp;rft.au=Moldovan-Loomis%2C+Cristina&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Decker_(2008)-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Decker_(2008)_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Decker, Eva L.; Reski, Ralf (2007). \"Current achievements in the production of complex biopharmaceuticals with moss bioreactors\". <i>Bioprocess and Biosystems Engineering</i>. <b>31</b> (1): 3\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00449-007-0151-y\">10.1007/s00449-007-0151-y</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17701058\">17701058</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bioprocess+and+Biosystems+Engineering&amp;rft.atitle=Current+achievements+in+the+production+of+complex+biopharmaceuticals+with+moss+bioreactors&amp;rft.volume=31&amp;rft.issue=1&amp;rft.pages=3-9&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1007%2Fs00449-007-0151-y&amp;rft_id=info%3Apmid%2F17701058&amp;rft.aulast=Decker&amp;rft.aufirst=Eva+L.&amp;rft.au=Reski%2C+Ralf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://protalix.com/procellex-platform/overview-procellex-platform.asp\">Protalix website \u2013 technology platform</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20121027101102/http://protalix.com/procellex-platform/overview-procellex-platform.asp\">Archived</a> October 27, 2012, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\">Gali Weinreb and Koby Yeshayahou for Globes May 2, 2012. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.globes.co.il/serveen/globes/docview.asp?did=1000745325&amp;fid=1725\">FDA approves Protalix Gaucher treatment</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20130529030847/http://www.globes.co.il/serveen/globes/docview.asp?did=1000745325&amp;fid=1725\">Archived</a> May 29, 2013, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-BioPro-33\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-BioPro_33-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-BioPro_33-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-BioPro_33-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110718203226/http://www.bio-pro.de/magazin/thema/00178/index.html?lang=en\">\"Molecular Farming \u2013 Plant Bioreactors\"</a>. BioPro. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.bio-pro.de/magazin/thema/00178/index.html?lang=en\">the original</a> on 2011-07-18<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-09-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Molecular+Farming+%E2%80%93+Plant+Bioreactors&amp;rft.pub=BioPro&amp;rft_id=http%3A%2F%2Fwww.bio-pro.de%2Fmagazin%2Fthema%2F00178%2Findex.html%3Flang%3Den&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Thomson, JA (2006). <i>Seeds for the future: The impact of genetically modified crops on the environment</i>. Australia: Cornell University Press.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Seeds+for+the+future%3A+The+impact+of+genetically+modified+crops+on+the+environment&amp;rft.place=Australia&amp;rft.pub=Cornell+University+Press&amp;rft.date=2006&amp;rft.aulast=Thomson&amp;rft.aufirst=JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\"><span title=\"This citation requires a reference to the specific page or range of pages in which the material appears. (March 2013)\">page&#160;needed</span></a></i>&#93;</sup></span>\n</li>\n<li id=\"cite_note-wired-35\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-wired_35-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-wired_35-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-wired_35-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Mandel, Charles (2001-11-06). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wired.com/medtech/health/news/2001/11/48108\">\"Molecular Farming Under Fire\"</a>. wired<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-09-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Molecular+Farming+Under+Fire&amp;rft.date=2001-11-06&amp;rft.aulast=Mandel&amp;rft.aufirst=Charles&amp;rft_id=https%3A%2F%2Fwww.wired.com%2Fmedtech%2Fhealth%2Fnews%2F2001%2F11%2F48108&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.molecularfarming.com/about.html\">\"Protein Products for Future Global Good\"</a>. molecularfarming.com<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-09-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Protein+Products+for+Future+Global+Good&amp;rft.pub=molecularfarming.com&amp;rft_id=http%3A%2F%2Fwww.molecularfarming.com%2Fabout.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.dowagro.com/animalhealth/resources/news/20060131b.htm\">Retrieved on 15 May 2007</a></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\">Margret Engelhard, Kristin Hagen, Felix Thiele (eds). (2007)  Pharming A New Branch of Biotechnology <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.ea-aw.de/fileadmin/downloads/Graue_Reihe/GR_43_Pharming_062007.pdf\">[1]</a></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.labtimes.org/labtimes/issues/lt2012/lt04/lt_2012_04_38_40.pdf\">Farming for Pharma</a></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ime.fraunhofer.de/en/about_us.html\">Fraunhofer website</a></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharma-planta.net/index.php?pg=58\">Pharma Planta website</a></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharma-planta.net/index.php?pg=61\">FAQ page</a></span>\n</li>\n<li id=\"cite_note-Brennan-43\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Brennan_43-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Brennan_43-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Brennan_43-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">Brennan, Zachary. Brazilian JV looks to tap plant-based manufacturing system for biosimilars. BioPharma-Reporter.com, 23-Jul-2014.</span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.gtc-bio.com/\">GTC website</a></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.icongenetics.com/html/5948.htm\">Press release on opening Halle facility</a></span>\n</li>\n<li id=\"cite_note-NHL-Launch-46\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NHL-Launch_46-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NHL-Launch_46-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.icongenetics.com/html/5954.htm\">Icon press release on clinical trial launch</a></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.bigmap.iastate.edu/images/BIGMAP%20newsletter%20spring06.pdf\">Iowa State Ag School 2006 Newsletter</a></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.aphis.usda.gov/brs/aphisdocs/08_057109r_nds.pdf\">APHIS approval</a></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://psychcentral.com/news/archives/2006-06/isu-isp062306.html\">Iowa State plant scientists tweak their biopharmaceutical corn research project</a></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.kbpllc.com/Home.aspx\">Kentucky Bioprocessing website</a></span>\n</li>\n<li id=\"cite_note-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-51\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vezina, Louis-P.; D'Aoust, Marc Andre; Landry, Nathalie; Couture, Manon M.J.; Charland, Nathalie; Barbeau, Brigitte; Sheldon, Andrew J. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.biopharminternational.com/biopharm/Upstream+Processing/Plants-As-an-Innovative-and-Accelerated-Vaccine-Ma/ArticleStandard/Article/detail/718082\">\"Plants As an Innovative and Accelerated Vaccine-Manufacturing Solution\"</a>. <i>BioPharm International Supplements</i>. <b>24</b> (5): s27\u201330.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioPharm+International+Supplements&amp;rft.atitle=Plants+As+an+Innovative+and+Accelerated+Vaccine-Manufacturing+Solution&amp;rft.volume=24&amp;rft.issue=5&amp;rft.pages=s27-30&amp;rft.date=2011&amp;rft.aulast=Vezina&amp;rft.aufirst=Louis-P.&amp;rft.au=D%27Aoust%2C+Marc+Andre&amp;rft.au=Landry%2C+Nathalie&amp;rft.au=Couture%2C+Manon+M.J.&amp;rft.au=Charland%2C+Nathalie&amp;rft.au=Barbeau%2C+Brigitte&amp;rft.au=Sheldon%2C+Andrew+J.&amp;rft_id=http%3A%2F%2Fwww.biopharminternational.com%2Fbiopharm%2FUpstream%2BProcessing%2FPlants-As-an-Innovative-and-Accelerated-Vaccine-Ma%2FArticleStandard%2FArticle%2Fdetail%2F718082&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.medicago.com/English/Technologies/Why-Plants/Alfalfa/default.aspx\">Alfalfa page on Medicago website</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20121001022426/http://www.medicago.com/English/Technologies/Why-Plants/Alfalfa/default.aspx\">Archived</a> October 1, 2012, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharming.com/\">Company website</a></span>\n</li>\n<li id=\"cite_note-PPL-Press-54\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-PPL-Press_54-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-PPL-Press_54-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.in-pharmatechnologist.com/Processing/Pharming-buys-up-PPL-s-patent-estate\">Press on Pharming Purchase of PPL assets</a></span>\n</li>\n<li id=\"cite_note-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-55\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.phytonbiotech.com/index-2.html\">Phyton Biotech Official Website</a></span>\n</li>\n<li id=\"cite_note-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-56\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.planetbiotechnology.com/\">Company website</a></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.plantformcorp.com/\">Company website</a></span>\n</li>\n<li id=\"cite_note-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-58\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090108160917/http://www.seedquest.com/News/releases/2003/august/6457.htm\">Press release from internet archive</a></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=33330\">Bloomberg BusinessWeek Profile</a></span>\n</li>\n<li id=\"cite_note-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-60\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=6741964\">http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=6741964</a></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.stineseed.com/about-stine/media/company-leadership/harry-h-stine/\">Stine Seeds Website</a></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://tsdr.uspto.gov/#caseNumber=78179017&amp;caseType=SERIAL_NO&amp;searchType=statusSearchUSPTO\">Trademark listing</a></span>\n</li>\n<li id=\"cite_note-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-63\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ray, Kevin; Jalili, Pegah R. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.biopharminternational.com/biopharm/Quality/Characterization-of-TrypZean-a-Plant-Based-Alterna/ArticleStandard/Article/detail/742608\">\"Characterization of TrypZean: a Plant-Based Alternative to Bovine-Derived Trypsin (Peer-Reviewed)\"</a>. <i>BioPharm International</i>. <b>24</b> (10): 44\u20138.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioPharm+International&amp;rft.atitle=Characterization+of+TrypZean%3A+a+Plant-Based+Alternative+to+Bovine-Derived+Trypsin+%28Peer-Reviewed%29&amp;rft.volume=24&amp;rft.issue=10&amp;rft.pages=44-8&amp;rft.date=2011&amp;rft.aulast=Ray&amp;rft.aufirst=Kevin&amp;rft.au=Jalili%2C+Pegah+R.&amp;rft_id=http%3A%2F%2Fwww.biopharminternational.com%2Fbiopharm%2FQuality%2FCharacterization-of-TrypZean-a-Plant-Based-Alterna%2FArticleStandard%2FArticle%2Fdetail%2F742608&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-64\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.sigmaaldrich.com/life-science/metabolomics/enzyme-explorer/analytical-enzymes/trypzean.html\">Sigma Catalog</a></span>\n</li>\n<li id=\"cite_note-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-65\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.goldenrice.org/Content3-Why/why3_FAQ.php#Syngenta\">FAQ page</a></span>\n</li>\n<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external autonumber\" href=\"https://sols.asu.edu/people/charles-arntzen\">[2]</a></span>\n</li>\n<li id=\"cite_note-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-67\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Khamsi, Roxanne (2005). \"Potatoes pack a punch against hepatitis B\". <i>News@nature</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/news050214-2\">10.1038/news050214-2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=News%40nature&amp;rft.atitle=Potatoes+pack+a+punch+against+hepatitis+B&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1038%2Fnews050214-2&amp;rft.aulast=Khamsi&amp;rft.aufirst=Roxanne&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-68\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.aphis.usda.gov/brs/aphisdocs/10_047102r_nds.pdf\">\"NEPA Decision Summary for Permit #10-047-102r\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <a href=\"/wiki/Animal_and_Plant_Health_Inspection_Service\" title=\"Animal and Plant Health Inspection Service\">Animal and Plant Health Inspection Service</a>. March 10, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NEPA+Decision+Summary+for+Permit+%2310-047-102r&amp;rft.pub=Animal+and+Plant+Health+Inspection+Service&amp;rft.date=2010-03-10&amp;rft_id=http%3A%2F%2Fwww.aphis.usda.gov%2Fbrs%2Faphisdocs%2F10_047102r_nds.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-69\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.officeofresearch.wsu.edu/mps/researchers/vonwettstein.aspx\">Wettstein lab webpage</a></span>\n</li>\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.molecularfarming.org/\">COST Action FA0804 Official Website</a></span>\n</li>\n<li id=\"cite_note-71\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-71\">^</a></b></span> <span class=\"reference-text\">Ward, Andrew (8 August 2014) <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ft.com/cms/s/0/3925a80e-1e32-11e4-bb68-00144feabdc0.html#axzz39ok7ETQX\">Biotech groups face ethical dilemmas in race for Ebola Cure</a>, Financial Times, Page 4, Internet article retrieved 8 August 2014</span>\n</li>\n<li id=\"cite_note-72\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-72\">^</a></b></span> <span class=\"reference-text\">Langreth, Robert, et al (5 August 2014) <a rel=\"nofollow\" class=\"external text\" href=\"https://www.bloomberg.com/news/2014-08-05/ebola-drug-made-from-tobacco-plant-saves-u-s-aid-workers.html\">Ebola Drug Made From Tobacco Plant Saves U.S. Aid Workers</a> Bloomberg News, Retrieved 8 August 2014</span>\n</li>\n<li id=\"cite_note-73\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-73\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2009109054\">Published PCT Application</a></span>\n</li>\n<li id=\"cite_note-74\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-74\">^</a></b></span> <span class=\"reference-text\">CEO Sam Huttenbauer testified before Congress in 2005 about their GM flax efforts <a rel=\"nofollow\" class=\"external text\" href=\"http://www.gpo.gov/fdsys/pkg/CHRG-109hhrg23179/pdf/CHRG-109hhrg23179.pdf\">Testimony</a></span>\n</li>\n<li id=\"cite_note-75\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-75\">^</a></b></span> <span class=\"reference-text\">Web search on October 6, 2012, found no website for this company and found that executives are all with other companies.</span>\n</li>\n<li id=\"cite_note-76\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-76\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=5863309\">Bloomberg BusinessWeek Profile</a></span>\n</li>\n<li id=\"cite_note-77\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-77\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.in-pharmatechnologist.com/Ingredients/Plant-production-for-cancer-protein\">Plant production for cancer protein Sept 22, 2003</a></span>\n</li>\n<li id=\"cite_note-78\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-78\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.prnewswire.com/news-releases/tanox-to-acquire-antibodies-from-sunol-molecular-corp-for-potential-treatment-of-inflammatory-disease-cancer-54351832.html\">Press Release</a></span>\n</li>\n<li id=\"cite_note-79\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-79\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://contracts.onecle.com/tanox/sunol.apa.2005.03.25.shtml\">Purchase contract</a></span>\n</li>\n<li id=\"cite_note-80\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-80\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.businesswire.com/news/home/20080212005194/en/Altor-BioScience-In-Licenses-Tissue-Factor-Antagonists-Genentech\">Press Release</a></span>\n</li>\n<li id=\"cite_note-81\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-81\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://altorbioscience.com/team.html\">Altor website</a></span>\n</li>\n<li id=\"cite_note-82\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-82\">^</a></b></span> <span class=\"reference-text\">Clinical trial number <i><a rel=\"nofollow\" class=\"external text\" href=\"https://www.clinicaltrials.gov/show/NCT00879606\">NCT00879606</a></i> for \"Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome\" at <a href=\"/wiki/ClinicalTrials.gov\" title=\"ClinicalTrials.gov\">ClinicalTrials.gov</a></span>\n</li>\n<li id=\"cite_note-83\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-83\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jiao, J.-a.; Kelly, A. B.; Marzec, U. M.; Nieves, E.; Acevedo, J.; Burkhardt, M.; Edwards, A.; Zhu, X.-y.; Chavaillaz, P.-A. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2927860\">\"Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site\"</a>. <i>Thrombosis and Haemostasis</i>. <b>103</b> (1): 224\u201333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1160/TH09-06-0400\">10.1160/TH09-06-0400</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2927860\">2927860</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20062929\">20062929</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Thrombosis+and+Haemostasis&amp;rft.atitle=Inhibition+of+acute+vascular+thrombosis+in+chimpanzees+by+an+anti-human+tissue+factor+antibody+targeting+the+factor+X+binding+site&amp;rft.volume=103&amp;rft.issue=1&amp;rft.pages=224-33&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2927860&amp;rft_id=info%3Apmid%2F20062929&amp;rft_id=info%3Adoi%2F10.1160%2FTH09-06-0400&amp;rft.aulast=Jiao&amp;rft.aufirst=J.-a.&amp;rft.au=Kelly%2C+A.+B.&amp;rft.au=Marzec%2C+U.+M.&amp;rft.au=Nieves%2C+E.&amp;rft.au=Acevedo%2C+J.&amp;rft.au=Burkhardt%2C+M.&amp;rft.au=Edwards%2C+A.&amp;rft.au=Zhu%2C+X.-y.&amp;rft.au=Chavaillaz%2C+P.-A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2927860&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-84\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-84\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.theguardian.com/science/2001/sep/09/gm.food\">Guardian report Sept 2001</a></span>\n</li>\n<li id=\"cite_note-85\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-85\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.trelys.com/news050604.aspx\">Trelys press release</a></span>\n</li>\n<li id=\"cite_note-86\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-86\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Lamb, Celia (2006-01-13). <a rel=\"nofollow\" class=\"external text\" href=\"http://sacramento.bizjournals.com/sacramento/stories/2006/01/16/story1.html\">\"Large Scale files Ch. 11 after closing\"</a>. <i><a href=\"/wiki/Sacramento_Business_Journal\" class=\"mw-redirect\" title=\"Sacramento Business Journal\">Sacramento Business Journal</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-05-10</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Sacramento+Business+Journal&amp;rft.atitle=Large+Scale+files+Ch.+11+after+closing&amp;rft.date=2006-01-13&amp;rft.aulast=Lamb&amp;rft.aufirst=Celia&amp;rft_id=http%3A%2F%2Fsacramento.bizjournals.com%2Fsacramento%2Fstories%2F2006%2F01%2F16%2Fstory1.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-87\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-87\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.businesswire.com/news/home/20040304005618/en/Large-Scale-Biology-Corporation-Announces-Biomanufacturing-Commercial\">Biomanufacturing Press Release</a></span>\n</li>\n<li id=\"cite_note-88\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-88\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.sigmaaldrich.com/catalog/product/sigma/a6103?lang=en&amp;region=US\">Sigma catalog Aprotinin</a></span>\n</li>\n<li id=\"cite_note-89\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-89\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharmaclient.net/biotech/memories.php\">History of bankrupt biotech companies</a></span>\n</li>\n<li id=\"cite_note-90\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-90\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://cordis.europa.eu/fetch?CALLER=EN_PARTNERS&amp;ACTION=D&amp;DOC=432&amp;CAT=PART&amp;QUERY=012c1391b59f:da0f:58589b33&amp;RCN=73876\">Cordis entry on Novoplant</a></span>\n</li>\n<li id=\"cite_note-91\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-91\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.aphis.usda.gov/brs/aphisdocs/06_335101r_nds.pdf\">APHIS approval</a></span>\n</li>\n<li id=\"cite_note-92\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-92\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.affitech.com/about-us/management-team/sergej-m-kiprijanov\">Kiprijanov biography</a></span>\n</li>\n<li id=\"cite_note-93\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-93\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.bizjournals.com/pittsburgh/stories/2003/04/07/daily30.html?page=all\">UPMC buys PPL assets</a></span>\n</li>\n<li id=\"cite_note-BankruptcyAnnouncement-94\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-BankruptcyAnnouncement_94-0\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.newswire.ca/en/story/975453/sembiosys-announces-first-quarter-results-and-provides-update-on-activities\">Press release May 15, 2012: SemBioSys Announces First Quarter Results and Provides Update on Activities</a></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=13\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><i>Biotech firm puts off rice crop here But company says it plans to sow next year</i>. <i>St. Louis Post-Dispatch</i>. April 29, 2005. Pg. A3.</li>\n<li><i>Biotech potato provides hepatitis vaccine</i>. <i>The Atlanta Journal-Constitution</i>. February 15, 2005. Pg. 3A.</li>\n<li><i>Biotechnology Venture Hits Unexpected Snags</i>. <i>The New York Times</i>. November 23, 2001. Pg. 5.</li>\n<li><i>Canadian scientists make insulin from plants: 'Bio-pharming' poised to meet huge diabetes demand at less cost</i>. The Ottawa Citizen. February 27, 2005. Pg. A1.</li>\n<li><i>GM corn set to stop man spreading his seed</i>. The Observer. September 9, 2001. Pg. 1.</li>\n<li><i>Pharming plans transgenic first</i>. Financial Times. May 3, 2005. Pg. 18.</li>\n<li><i>USDA says bio-crop safeguards are tighter ProdiGene is back in Nebraska with test plot</i>. Omaha World Herald. June 2, 2004 Pg. 01D</li>\n<li><i>Release Permits for Pharmaceuticals, Industrials, Value Added Proteins for Human Consumption, or for Phytoremediation Granted or Pending by APHIS as of March 29, 2006</i>. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.aphis.usda.gov/brs/ph_permits.html\">[3]</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharming_(genetics)&amp;action=edit&amp;section=14\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.molecularfarming.com/\">molecularfarming.com Official site</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110718203226/http://www.bio-pro.de/magazin/thema/00178/index.html?lang=en\">Molecular Farming \u2013 Plant Bioreactors</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20110718202735/http://www.bio-pro.de/magazin/umfeld/archiv_2005/index.html?lang=en&amp;artikelid=%2Fartikel%2F03016%2Findex.html\">Moss bioreactors do not smell (Interview with </a><a href=\"/wiki/Ralf_Reski\" title=\"Ralf Reski\">Ralf Reski</a>)</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.gmo-safety.eu/topic/256?mode=doc\">Molecular Pharming \u2013 pharmaceuticals with the help of GM plants</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20050404083632/http://gslc.genetics.utah.edu/features/pharming/\">Pharming for Farmaceuticals</a></li>\n<li><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pewtrusts.org/our_work_report_detail.aspx?id=35424\">\"Pharming the Field: A Look at the Benefits and Risks of Bioengineering Plants to Produce Pharmaceuticals\"</a>. The Pew Charitable Trusts. July 18, 2002.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharming+the+Field%3A+A+Look+at+the+Benefits+and+Risks+of+Bioengineering+Plants+to+Produce+Pharmaceuticals&amp;rft.pub=The+Pew+Charitable+Trusts&amp;rft.date=2002-07-18&amp;rft_id=http%3A%2F%2Fwww.pewtrusts.org%2Four_work_report_detail.aspx%3Fid%3D35424&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharming+%28genetics%29\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.aphis.usda.gov/brs/index.html\">USDA-APHIS Biotechnology Regulatory Services</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.epa.gov/biotech_rule/index.htm\">EPA Biotechnology page</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cfsan.fda.gov/~lrd/biotechm.html\">FDA Biotechnology page</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20060409171359/http://usbiotechreg.nbii.gov/\">Homepage of the Coordinated Framework for Regulation of Biotechnology</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.aphis.usda.gov/brs/pdf/Pharma_Guidance.pdf\">Draft Guidance for APHIS Permits for Field Testing or Movement of Organisms with Pharmaceutical or Industrial Intent</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.plantpharma.org\">PlantPharma.org Online Community</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.nsf.gov/od/lpa/nsf50/nsfoutreach/htm/n50_z2/pages_z3/25_pg.htm\">National Science Foundation</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharma-planta.org\">Pharma-Planta Consortium</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.bio.org/\">Biotechnology Industry Organization</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://cpmp2005.org/\">Society for Moleculture, a non-for-profit organisation for plant- factories, Qu\u00e9bec, Canada</a></li></ul>\n<p><br />\n</p>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Genetic_engineering\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Genetic_engineering\" title=\"Template:Genetic engineering\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Genetic_engineering\" title=\"Template talk:Genetic engineering\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Genetic_engineering&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Genetic_engineering\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Genetic_engineering\" title=\"Genetic engineering\">Genetic engineering</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_organism\" title=\"Genetically modified organism\">Genetically <br />modified<br /> organisms</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_crops\" title=\"Genetically modified crops\">Crops</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_maize\" title=\"Genetically modified maize\">Maize</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/MON_810\" title=\"MON 810\">MON 810</a></li>\n<li><a href=\"/wiki/MON_863\" title=\"MON 863\">MON 863</a></li>\n<li><a href=\"/wiki/Starlink_corn_recall#StarLink_corn\" class=\"mw-redirect\" title=\"Starlink corn recall\">StarLink</a></li>\n<li><a href=\"/wiki/List_of_varieties_of_genetically_modified_maize\" title=\"List of varieties of genetically modified maize\">List of varieties of genetically modified maize</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_potato\" class=\"mw-redirect\" title=\"Genetically modified potato\">Potato</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Amflora\" title=\"Amflora\">Amflora</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_rice\" title=\"Genetically modified rice\">Rice</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Golden_rice\" title=\"Golden rice\">Golden rice</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_soybean\" title=\"Genetically modified soybean\">Soybean</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Roundup_ready_soybean\" class=\"mw-redirect\" title=\"Roundup ready soybean\">Roundup ready soybean</a></li>\n<li><a href=\"/wiki/Vistive_Gold\" title=\"Vistive Gold\">Vistive Gold</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_tomato\" title=\"Genetically modified tomato\">Tomato</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Flavr_Savr\" title=\"Flavr Savr\">Flavr Savr</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Cotton#Genetic_modification\" title=\"Cotton\">Cotton</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Bt_cotton\" title=\"Bt cotton\">Bt cotton</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Arctic_Apples\" title=\"Arctic Apples\">Apple</a></li>\n<li><a href=\"/wiki/Arabidopsis_thaliana\" title=\"Arabidopsis thaliana\">Arabidopsis</a></li>\n<li><a href=\"/wiki/Bt_brinjal\" title=\"Bt brinjal\">Brinjal</a></li>\n<li><a href=\"/wiki/Canola#Genetic_modification_issues\" class=\"mw-redirect\" title=\"Canola\">Canola</a></li>\n<li><a href=\"/wiki/Papaya\" title=\"Papaya\">Papaya</a></li>\n<li><a href=\"/wiki/Blue_rose\" title=\"Blue rose\">Rose</a></li>\n<li><a href=\"/wiki/SmartStax\" title=\"SmartStax\">SmartStax</a></li>\n<li><a href=\"/wiki/Genetically_modified_sugar_beet\" title=\"Genetically modified sugar beet\">Sugar beet</a></li>\n<li><a href=\"/wiki/Tobacco#Genetic_modification\" title=\"Tobacco\">Tobacco</a></li>\n<li><a href=\"/wiki/Genetically_modified_tree\" title=\"Genetically modified tree\">Trees</a></li>\n<li><a href=\"/wiki/Genetically_modified_wheat\" title=\"Genetically modified wheat\">Wheat</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_mammal\" title=\"Genetically modified mammal\">Mammals</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Genetically_modified_mouse\" title=\"Genetically modified mouse\">Mouse</a>\n<ul><li><a href=\"/wiki/Knockout_mouse\" title=\"Knockout mouse\">Knockout mouse</a></li>\n<li><a href=\"/wiki/Oncomouse\" title=\"Oncomouse\">Oncomouse</a></li></ul></li>\n<li><a href=\"/wiki/Enviropig\" title=\"Enviropig\">Enviropig</a></li>\n<li><a href=\"/wiki/Herman_the_Bull\" title=\"Herman the Bull\">Herman the Bull</a></li>\n<li><a href=\"/wiki/Knockout_rat\" title=\"Knockout rat\">Knockout rat</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other animals</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Genetically_modified_insect\" title=\"Genetically modified insect\">Insects</a></li>\n<li><a href=\"/wiki/Genetically_modified_fish\" title=\"Genetically modified fish\">Fish</a>\n<ul><li><a href=\"/wiki/GloFish\" title=\"GloFish\">Glofish</a></li>\n<li><a href=\"/wiki/Genetically_modified_salmon\" class=\"mw-redirect\" title=\"Genetically modified salmon\">Salmon</a></li></ul></li>\n<li><a href=\"/wiki/Genetically_modified_bird\" title=\"Genetically modified bird\">Birds</a></li>\n<li><a href=\"/wiki/Genetically_modified_organism#Frogs\" title=\"Genetically modified organism\">Frogs</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetically_modified_bacteria\" title=\"Genetically modified bacteria\">Bacteria</a><br /> and <a href=\"/wiki/Genetically_modified_virus\" title=\"Genetically modified virus\">viruses</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Ice-minus_bacteria\" title=\"Ice-minus bacteria\">Ice-minus bacteria</a></li>\n<li><a href=\"/wiki/Hepatitis_B_vaccine\" title=\"Hepatitis B vaccine\">Hepatitis B vaccine</a></li>\n<li><a href=\"/wiki/Oncolytic_virus\" title=\"Oncolytic virus\">Oncolytic virus</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genetic_engineering_techniques\" title=\"Genetic engineering techniques\">Processes</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Transformation_(genetics)\" title=\"Transformation (genetics)\">Inserting DNA</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Agrobacterium\" title=\"Agrobacterium\">Agrobacteria</a></li>\n<li><a href=\"/wiki/Gene_gun\" title=\"Gene gun\">Biolistics</a></li>\n<li><a href=\"/wiki/Electroporation\" title=\"Electroporation\">Electroporation</a></li>\n<li><a href=\"/wiki/Genetic_transduction\" class=\"mw-redirect\" title=\"Genetic transduction\">Genetic transduction</a></li>\n<li><a href=\"/wiki/Lipofection\" class=\"mw-redirect\" title=\"Lipofection\">Lipofection</a></li>\n<li><a href=\"/wiki/Microinjection\" title=\"Microinjection\">Microinjection</a></li>\n<li><a href=\"/wiki/Somatic_cell_nuclear_transfer\" title=\"Somatic cell nuclear transfer\">Somatic cell nuclear transfer</a></li>\n<li><a href=\"/wiki/Transfection\" title=\"Transfection\">Transfection</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Types</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Recombinant_DNA\" title=\"Recombinant DNA\">Recombinant DNA</a></li>\n<li><a href=\"/wiki/Transgenesis\" class=\"mw-redirect\" title=\"Transgenesis\">Transgenesis</a></li>\n<li><a href=\"/wiki/Cisgenesis\" title=\"Cisgenesis\">Cisgenesis</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Uses</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">In agriculture</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Genetically_modified_food\" title=\"Genetically modified food\">Genetically modified food</a>\n<ul><li><a href=\"/wiki/Genetically_modified_food_controversies\" title=\"Genetically modified food controversies\">Controversies</a></li></ul></li>\n<li><a class=\"mw-selflink selflink\">Pharming</a></li>\n<li>Companies\n<ul><li><a href=\"/wiki/BASF_Plant_Science\" title=\"BASF Plant Science\">BASF</a></li>\n<li><a href=\"/wiki/Bayer#Bayer_CropScience\" title=\"Bayer\">Bayer</a></li>\n<li><a href=\"/wiki/Dow_AgroSciences\" title=\"Dow AgroSciences\">Dow AgroSciences</a></li>\n<li><a href=\"/wiki/DuPont_Pioneer\" title=\"DuPont Pioneer\">DuPont Pioneer</a></li>\n<li><a href=\"/wiki/Monsanto\" title=\"Monsanto\">Monsanto</a></li>\n<li><a href=\"/wiki/Syngenta\" title=\"Syngenta\">Syngenta</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">In <a href=\"/wiki/Human_genetic_engineering\" class=\"mw-redirect\" title=\"Human genetic engineering\">humans</a> and<br /> diagnostics</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Gene_therapy\" title=\"Gene therapy\">Gene therapy</a></li>\n<li><a href=\"/wiki/Genetic_enhancement\" class=\"mw-redirect\" title=\"Genetic enhancement\">Genetic enhancement</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">In research</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Gene_knockout\" title=\"Gene knockout\">Gene knockout</a></li>\n<li><a href=\"/wiki/Gene_knockdown\" title=\"Gene knockdown\">Gene knockdown</a></li>\n<li><a href=\"/wiki/Gene_targeting\" title=\"Gene targeting\">Gene targeting</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Related<br /> articles</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Transgene\" title=\"Transgene\">Transgene</a></li>\n<li><a href=\"/wiki/Detection_of_genetically_modified_organisms\" title=\"Detection of genetically modified organisms\">Detection of genetically modified organisms</a></li>\n<li><a href=\"/wiki/Genetic_pollution\" title=\"Genetic pollution\">Genetic pollution</a></li>\n<li><a href=\"/wiki/Genetics_in_fiction\" title=\"Genetics in fiction\">Genetics in fiction</a></li>\n<li><a href=\"/wiki/Human_enhancement\" title=\"Human enhancement\">Human enhancement</a></li>\n<li><a href=\"/wiki/Reverse_transfection\" title=\"Reverse transfection\">Reverse transfection</a></li>\n<li><a href=\"/wiki/Transhumanism\" title=\"Transhumanism\">Transhumanism</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Regulation_of_genetic_engineering\" title=\"Regulation of genetic engineering\">Regulation</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cartagena_Protocol_on_Biosafety\" title=\"Cartagena Protocol on Biosafety\">Cartagena Protocol on Biosafety</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Geography</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Genetic_engineering_in_Europe\" class=\"mw-redirect\" title=\"Genetic engineering in Europe\">Europe</a></li>\n<li><a href=\"/wiki/Genetic_engineering_in_Africa\" class=\"mw-redirect\" title=\"Genetic engineering in Africa\">Africa</a></li>\n<li><a href=\"/wiki/Genetic_engineering_in_Asia\" class=\"mw-redirect\" title=\"Genetic engineering in Asia\">Asia</a></li>\n<li><a href=\"/wiki/Genetic_engineering_in_North_America\" class=\"mw-redirect\" title=\"Genetic engineering in North America\">North America</a> (<a href=\"/wiki/Genetic_engineering_in_the_United_States\" class=\"mw-redirect\" title=\"Genetic engineering in the United States\">US</a>)</li>\n<li><a href=\"/wiki/Genetic_engineering_in_South_America\" class=\"mw-redirect\" title=\"Genetic engineering in South America\">South America</a></li>\n<li><a href=\"/wiki/Genetic_engineering_in_Oceania\" class=\"mw-redirect\" title=\"Genetic engineering in Oceania\">Oceania</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Similar fields</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Synthetic_biology\" title=\"Synthetic biology\">Synthetic biology</a></li>\n<li><a href=\"/wiki/Cloning\" title=\"Cloning\">Cloning</a></li>\n<li><a href=\"/wiki/Stem_cell\" title=\"Stem cell\">Stem cell research</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div>\n<ul><li><a href=\"/wiki/Biology\" title=\"Biology\">Biology</a></li>\n<li><a href=\"/wiki/Genetics\" title=\"Genetics\">Genetics</a></li>\n<li><a href=\"/wiki/Biotechnology\" title=\"Biotechnology\">Biotechnology</a></li>\n<li><a href=\"/wiki/Bioethics\" title=\"Bioethics\">Bioethics</a></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw1329\nCached time: 20180909111128\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.568 seconds\nReal time usage: 0.653 seconds\nPreprocessor visited node count: 3055/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 117664/2097152 bytes\nTemplate argument size: 1829/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 73987/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.212/10.000 seconds\nLua memory usage: 5.07 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  489.061      1 -total\n 69.23%  338.594      1 Template:Reflist\n 19.65%   96.087     19 Template:Cite_journal\n 11.69%   57.173      7 Template:Cite_web\n 10.36%   50.668      3 Template:Fix\n 10.08%   49.308      1 Template:About\n  9.92%   48.501      2 Template:Page_needed\n  6.00%   29.325      5 Template:Navbox\n  4.89%   23.911      3 Template:Delink\n  4.66%   22.813      5 Template:Category_handler\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1749134-0!canonical and timestamp 20180909111128 and revision id 853691567\n -->\n</div>"},"langlinks":[{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Pharming","langname":"Catalan","autonym":"catal\u00e0","*":"Pharming"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Pharmapflanze","langname":"German","autonym":"Deutsch","*":"Pharmapflanze"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Pharming_(biologie)","langname":"French","autonym":"fran\u00e7ais","*":"Pharming (biologie)"},{"lang":"id","url":"https://id.wikipedia.org/wiki/Pharming","langname":"Indonesian","autonym":"Bahasa Indonesia","*":"Pharming"},{"lang":"no","url":"https://no.wikipedia.org/wiki/Legemiddelproduksjon_via_genmodifisert_biosyntese","langname":"Norwegian","autonym":"norsk","*":"Legemiddelproduksjon via genmodifisert biosyntese"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E7%94%9F%E7%89%A9%E7%94%A2%E8%97%A5","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u751f\u7269\u7522\u85e5"}],"categories":[{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_page_number_citations_from_March_2013"},{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_March_2013"},{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"Pharming (Genetics)","*":"Genetically_modified_organisms"},{"sortkey":"Pharming (Genetics)","*":"Genetically_modified_organisms_in_agriculture"},{"sortkey":"Pharming (Genetics)","*":"Applied_genetics"},{"sortkey":"Pharming (Genetics)","*":"Drug_discovery"},{"sortkey":"Pharming (Genetics)","*":"Biotechnology"},{"sortkey":"Pharming (Genetics)","*":"Biological_engineering"},{"sortkey":"Pharming (Genetics)","*":"Genetic_engineering"},{"sortkey":"Pharming (Genetics)","*":"Molecular_biology"}],"links":[{"ns":14,"exists":"","*":"Category:Wikipedia articles needing page number citations from March 2013"},{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from March 2013"},{"ns":0,"exists":"","*":"Paywall"},{"ns":0,"exists":"","*":"ATryn"},{"ns":0,"exists":"","*":"Active pharmaceutical ingredients"},{"ns":0,"exists":"","*":"Activists"},{"ns":0,"exists":"","*":"Agrobacterium"},{"ns":0,"exists":"","*":"Alfalfa"},{"ns":0,"exists":"","*":"Alice v. CLS Bank"},{"ns":0,"exists":"","*":"Allergens"},{"ns":0,"exists":"","*":"Alpha 1-antitrypsin"},{"ns":0,"exists":"","*":"Alpha galactosidase"},{"ns":0,"exists":"","*":"American Red Cross"},{"ns":0,"exists":"","*":"Amflora"},{"ns":0,"exists":"","*":"Anheuser-Busch"},{"ns":0,"exists":"","*":"Animal and Plant Health Inspection Service"},{"ns":0,"exists":"","*":"Anthrax"},{"ns":0,"exists":"","*":"Antibodies"},{"ns":0,"exists":"","*":"Anticoagulant"},{"ns":0,"exists":"","*":"Antithrombin"},{"ns":0,"exists":"","*":"Antithrombin III"},{"ns":0,"exists":"","*":"Aprotinin"},{"ns":0,"exists":"","*":"Arabidopsis thaliana"},{"ns":0,"exists":"","*":"Arctic Apples"},{"ns":0,"exists":"","*":"BASF Plant Science"},{"ns":0,"exists":"","*":"Bacteria"},{"ns":0,"exists":"","*":"Bayer"},{"ns":0,"exists":"","*":"Beta carotene"},{"ns":0,"exists":"","*":"Bio/Technology"},{"ns":0,"exists":"","*":"Biodiversity"},{"ns":0,"exists":"","*":"Bioethics"},{"ns":0,"exists":"","*":"Biolex"},{"ns":0,"exists":"","*":"Biologic medical product"},{"ns":0,"exists":"","*":"Biology"},{"ns":0,"exists":"","*":"Biopharmaceutical"},{"ns":0,"exists":"","*":"Biopharmaceuticals"},{"ns":0,"exists":"","*":"Bioreactor"},{"ns":0,"exists":"","*":"Bioreactors"},{"ns":0,"exists":"","*":"Bioremediation"},{"ns":0,"exists":"","*":"Biosimilar"},{"ns":0,"exists":"","*":"Biotechnology"},{"ns":0,"exists":"","*":"Blood products"},{"ns":0,"exists":"","*":"Blue rose"},{"ns":0,"exists":"","*":"Bt brinjal"},{"ns":0,"exists":"","*":"Bt cotton"},{"ns":0,"exists":"","*":"Bubonic plague"},{"ns":0,"exists":"","*":"C1 inhibitor"},{"ns":0,"exists":"","*":"COST"},{"ns":0,"exists":"","*":"Canadian Food Inspection Agency"},{"ns":0,"exists":"","*":"Canola"},{"ns":0,"exists":"","*":"Cartagena Protocol on Biosafety"},{"ns":0,"exists":"","*":"Cell culture"},{"ns":0,"exists":"","*":"Chloroplasts"},{"ns":0,"exists":"","*":"Cholera"},{"ns":0,"exists":"","*":"Cisgenesis"},{"ns":0,"exists":"","*":"ClinicalTrials.gov"},{"ns":0,"exists":"","*":"Cloning"},{"ns":0,"exists":"","*":"Collagen"},{"ns":0,"exists":"","*":"Cotton"},{"ns":0,"exists":"","*":"Crop"},{"ns":0,"exists":"","*":"Cystic fibrosis"},{"ns":0,"exists":"","*":"Cytokines"},{"ns":0,"exists":"","*":"Dental caries"},{"ns":0,"exists":"","*":"Detection of genetically modified organisms"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Docetaxel"},{"ns":0,"exists":"","*":"Docosahexaenoic acid"},{"ns":0,"exists":"","*":"Dolly (sheep)"},{"ns":0,"exists":"","*":"Dow AgroSciences"},{"ns":0,"exists":"","*":"Dow Chemical Company"},{"ns":0,"exists":"","*":"Doxorubicin"},{"ns":0,"exists":"","*":"Drought resistance"},{"ns":0,"exists":"","*":"DuPont Pioneer"},{"ns":0,"exists":"","*":"Ebola virus disease"},{"ns":0,"exists":"","*":"Elastin"},{"ns":0,"exists":"","*":"Electroporation"},{"ns":0,"exists":"","*":"Emphysema"},{"ns":0,"exists":"","*":"Enviropig"},{"ns":0,"exists":"","*":"Epicyte"},{"ns":0,"exists":"","*":"Escherichia coli"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"Fabry disease"},{"ns":0,"exists":"","*":"Fibrinogen"},{"ns":0,"exists":"","*":"Flavr Savr"},{"ns":0,"exists":"","*":"Flax"},{"ns":0,"exists":"","*":"Food chain"},{"ns":0,"exists":"","*":"Fraunhofer Society"},{"ns":0,"exists":"","*":"G-CSF"},{"ns":0,"exists":"","*":"Gastric lipase"},{"ns":0,"exists":"","*":"Gastroenteritis"},{"ns":0,"exists":"","*":"Gaucher's disease"},{"ns":0,"exists":"","*":"Gene"},{"ns":0,"exists":"","*":"Gene flow"},{"ns":0,"exists":"","*":"Gene gun"},{"ns":0,"exists":"","*":"Gene knockdown"},{"ns":0,"exists":"","*":"Gene knockout"},{"ns":0,"exists":"","*":"Gene targeting"},{"ns":0,"exists":"","*":"Gene therapy"},{"ns":0,"exists":"","*":"Genentech"},{"ns":0,"exists":"","*":"Genetic engineering"},{"ns":0,"exists":"","*":"Genetic engineering in Africa"},{"ns":0,"exists":"","*":"Genetic engineering in Asia"},{"ns":0,"exists":"","*":"Genetic engineering in Europe"},{"ns":0,"exists":"","*":"Genetic engineering in North America"},{"ns":0,"exists":"","*":"Genetic engineering in Oceania"},{"ns":0,"exists":"","*":"Genetic engineering in South America"},{"ns":0,"exists":"","*":"Genetic engineering in the United States"},{"ns":0,"exists":"","*":"Genetic engineering techniques"},{"ns":0,"exists":"","*":"Genetic enhancement"},{"ns":0,"exists":"","*":"Genetic pollution"},{"ns":0,"exists":"","*":"Genetic transduction"},{"ns":0,"exists":"","*":"Genetically Modified"},{"ns":0,"exists":"","*":"Genetically modified"},{"ns":0,"exists":"","*":"Genetically modified bacteria"},{"ns":0,"exists":"","*":"Genetically modified bird"},{"ns":0,"exists":"","*":"Genetically modified crops"},{"ns":0,"exists":"","*":"Genetically modified fish"},{"ns":0,"exists":"","*":"Genetically modified food"},{"ns":0,"exists":"","*":"Genetically modified food controversies"},{"ns":0,"exists":"","*":"Genetically modified insect"},{"ns":0,"exists":"","*":"Genetically modified maize"},{"ns":0,"exists":"","*":"Genetically modified mammal"},{"ns":0,"exists":"","*":"Genetically modified mouse"},{"ns":0,"exists":"","*":"Genetically modified organism"},{"ns":0,"exists":"","*":"Genetically modified potato"},{"ns":0,"exists":"","*":"Genetically modified rice"},{"ns":0,"exists":"","*":"Genetically modified salmon"},{"ns":0,"exists":"","*":"Genetically modified soybean"},{"ns":0,"exists":"","*":"Genetically modified sugar beet"},{"ns":0,"exists":"","*":"Genetically modified tomato"},{"ns":0,"exists":"","*":"Genetically modified tree"},{"ns":0,"exists":"","*":"Genetically modified virus"},{"ns":0,"exists":"","*":"Genetically modified wheat"},{"ns":0,"exists":"","*":"Genetics"},{"ns":0,"exists":"","*":"Genetics in fiction"},{"ns":0,"exists":"","*":"Genzyme"},{"ns":0,"exists":"","*":"GloFish"},{"ns":0,"exists":"","*":"Glycosylation"},{"ns":0,"exists":"","*":"Goats"},{"ns":0,"exists":"","*":"Golden rice"},{"ns":0,"exists":"","*":"Growth factors"},{"ns":0,"exists":"","*":"Health"},{"ns":0,"exists":"","*":"Henry I. Miller"},{"ns":0,"exists":"","*":"Hepatitis B"},{"ns":0,"exists":"","*":"Hepatitis B vaccine"},{"ns":0,"exists":"","*":"Hepatitis C"},{"ns":0,"exists":"","*":"Herman the Bull"},{"ns":0,"exists":"","*":"Hormones"},{"ns":0,"exists":"","*":"Human diseases"},{"ns":0,"exists":"","*":"Human enhancement"},{"ns":0,"exists":"","*":"Human genetic engineering"},{"ns":0,"exists":"","*":"Human serum albumin"},{"ns":0,"exists":"","*":"Ice-minus bacteria"},{"ns":0,"exists":"","*":"Influenza vaccine"},{"ns":0,"exists":"","*":"Ingestion"},{"ns":0,"exists":"","*":"Insulin"},{"ns":0,"exists":"","*":"Insulin-like growth factor"},{"ns":0,"exists":"","*":"Intercellular adhesion molecule"},{"ns":0,"exists":"","*":"Interferon"},{"ns":0,"exists":"","*":"International Center for Technology Assessment"},{"ns":0,"exists":"","*":"Internet"},{"ns":0,"exists":"","*":"Knockout mouse"},{"ns":0,"exists":"","*":"Knockout rat"},{"ns":0,"exists":"","*":"Lactoferrin"},{"ns":0,"exists":"","*":"Lemna"},{"ns":0,"exists":"","*":"Lemna minor"},{"ns":0,"exists":"","*":"Library of Parliament"},{"ns":0,"exists":"","*":"Lipase"},{"ns":0,"exists":"","*":"Lipofection"},{"ns":0,"exists":"","*":"List of varieties of genetically modified maize"},{"ns":0,"exists":"","*":"Lysosomal lipase"},{"ns":0,"exists":"","*":"Lysozyme"},{"ns":0,"exists":"","*":"MON 810"},{"ns":0,"exists":"","*":"MON 863"},{"ns":0,"exists":"","*":"Maize"},{"ns":0,"exists":"","*":"Mapp Biopharmaceutical"},{"ns":0,"exists":"","*":"Mayo v. Prometheus"},{"ns":0,"exists":"","*":"Michael Quinion"},{"ns":0,"exists":"","*":"Microbial"},{"ns":0,"exists":"","*":"Microinjection"},{"ns":0,"exists":"","*":"Model organism"},{"ns":0,"exists":"","*":"Monsanto"},{"ns":0,"exists":"","*":"Monsanto Company"},{"ns":0,"exists":"","*":"Moss"},{"ns":0,"exists":"","*":"Nat. Biotechnol."},{"ns":0,"exists":"","*":"Newcastle disease"},{"ns":0,"exists":"","*":"Newcastle disease virus"},{"ns":0,"exists":"","*":"Non-Hodgkin's lymphoma"},{"ns":0,"exists":"","*":"OCLC"},{"ns":0,"exists":"","*":"Oncolytic virus"},{"ns":0,"exists":"","*":"Oncomouse"},{"ns":0,"exists":"","*":"Paclitaxel"},{"ns":0,"exists":"","*":"Papaya"},{"ns":0,"exists":"","*":"Papillomavirus"},{"ns":0,"exists":"","*":"Parliament of Canada"},{"ns":0,"exists":"","*":"Parvovirus"},{"ns":0,"exists":"","*":"Pathogens"},{"ns":0,"exists":"","*":"Pesticide resistance"},{"ns":0,"exists":"","*":"Pharmaceutical"},{"ns":0,"exists":"","*":"Pharmaceuticals"},{"ns":0,"exists":"","*":"Pharmacologically"},{"ns":0,"exists":"","*":"Pharming"},{"ns":0,"exists":"","*":"Pharming parties"},{"ns":0,"exists":"","*":"Physcomitrella patens"},{"ns":0,"exists":"","*":"Physiology"},{"ns":0,"exists":"","*":"Plants"},{"ns":0,"exists":"","*":"Pollination"},{"ns":0,"exists":"","*":"Polly and Molly"},{"ns":0,"exists":"","*":"Portmanteau"},{"ns":0,"exists":"","*":"Potato"},{"ns":0,"exists":"","*":"Potatoes"},{"ns":0,"exists":"","*":"Protease inhibitors"},{"ns":0,"exists":"","*":"Protein"},{"ns":0,"exists":"","*":"Protein-protein interaction"},{"ns":0,"exists":"","*":"Protein purification"},{"ns":0,"exists":"","*":"Protein synthesis"},{"ns":0,"exists":"","*":"Proteins"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Ralf Reski"},{"ns":0,"exists":"","*":"Receptor (biochemistry)"},{"ns":0,"exists":"","*":"Recombinant DNA"},{"ns":0,"exists":"","*":"Regulation of genetic engineering"},{"ns":0,"exists":"","*":"Regulation of the release of genetic modified organisms"},{"ns":0,"exists":"","*":"Reverse transfection"},{"ns":0,"exists":"","*":"Rice"},{"ns":0,"exists":"","*":"Roundup ready soybean"},{"ns":0,"exists":"","*":"Sacramento Business Journal"},{"ns":0,"exists":"","*":"Safflower"},{"ns":0,"exists":"","*":"San Diego, California"},{"ns":0,"exists":"","*":"Science (journal)"},{"ns":0,"exists":"","*":"SemBioSys Genetics Inc. (Calgary)"},{"ns":0,"exists":"","*":"Serum albumin"},{"ns":0,"exists":"","*":"Sheep milk"},{"ns":0,"exists":"","*":"Sigma-Aldrich"},{"ns":0,"exists":"","*":"SmartStax"},{"ns":0,"exists":"","*":"Somatic cell nuclear transfer"},{"ns":0,"exists":"","*":"Starlink corn recall"},{"ns":0,"exists":"","*":"Stem cell"},{"ns":0,"exists":"","*":"Streptococcus mutans"},{"ns":0,"exists":"","*":"Supply and demand"},{"ns":0,"exists":"","*":"Syngenta"},{"ns":0,"exists":"","*":"Synthetic biology"},{"ns":0,"exists":"","*":"Synthon (company)"},{"ns":0,"exists":"","*":"Taliglucerase alfa"},{"ns":0,"exists":"","*":"Tanox"},{"ns":0,"exists":"","*":"Taxanes"},{"ns":0,"exists":"","*":"Tobacco"},{"ns":0,"exists":"","*":"Tobacco mosaic virus"},{"ns":0,"exists":"","*":"Transfection"},{"ns":0,"exists":"","*":"Transformation (genetics)"},{"ns":0,"exists":"","*":"Transgene"},{"ns":0,"exists":"","*":"Transgenesis"},{"ns":0,"exists":"","*":"Transgenic maize"},{"ns":0,"exists":"","*":"Transhumanism"},{"ns":0,"exists":"","*":"Trastuzumab"},{"ns":0,"exists":"","*":"Trends Biotechnol."},{"ns":0,"exists":"","*":"Trends Plant Sci."},{"ns":0,"exists":"","*":"Trypsin"},{"ns":0,"exists":"","*":"USDA"},{"ns":0,"exists":"","*":"United States Department of Agriculture"},{"ns":0,"exists":"","*":"United States Supreme Court"},{"ns":0,"exists":"","*":"Vaccine"},{"ns":0,"exists":"","*":"Ventria Bioscience"},{"ns":0,"exists":"","*":"Veterinary"},{"ns":0,"exists":"","*":"Vistive Gold"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"exists":"","*":"World Wide Words"},{"ns":0,"exists":"","*":"Yeast"},{"ns":0,"exists":"","*":"ZMapp"},{"ns":0,"*":"Seminal plasma"},{"ns":0,"*":"Medicago (company)"},{"ns":10,"exists":"","*":"Template:Genetic engineering"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources"},{"ns":11,"exists":"","*":"Template talk:Genetic engineering"}],"templates":[{"ns":10,"exists":"","*":"Template:About"},{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Closed access"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Page needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Cite press release"},{"ns":10,"exists":"","*":"Template:Unreliable source?"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:ClinicalTrialsGov"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Genetic engineering"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:About"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Pagetype"},{"ns":828,"exists":"","*":"Module:Pagetype/config"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Namespace detect"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Closed_Access_logo_alternative.svg","Lock-green.svg"],"externallinks":["http://www.worldwidewords.org/turnsofphrase/tp-mol2.htm","http://www2.parl.gc.ca/Content/LOP/ResearchPublications/prb0509-e.htm","//doi.org/10.1016/S1360-1385(00)01680-0","//www.ncbi.nlm.nih.gov/pubmed/10871897","//doi.org/10.1038/nbt0503-480","//www.ncbi.nlm.nih.gov/pubmed/12721561","http://people.forestry.oregonstate.edu/steve-strauss/sites/people.forestry.oregonstate.edu.steve-strauss/files/Is%20drought%20over%20for%20pharming%20Science%202007.pdf","//doi.org/10.1126/science.320.5875.473","//www.ncbi.nlm.nih.gov/pubmed/18436771","//doi.org/10.1038/nbt0390-217","//www.ncbi.nlm.nih.gov/pubmed/1366404","//www.worldcat.org/oclc/74353733","//doi.org/10.1016/j.tibtech.2003.10.002","//www.ncbi.nlm.nih.gov/pubmed/14624867","//doi.org/10.1038/nrg1177","//www.ncbi.nlm.nih.gov/pubmed/14526375","http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/General_Information/cell_culture.Par.0001.File.tmp/cell_culture.pdf","http://www.prnewswire.com/news-releases/prodigene-launches-first-large-scale-up-manufacturing-of-recombinant-protein-from-plant-system-75984427.html","http://ngin.tripod.com/151102a.htm","//doi.org/10.1196/annals.1408.009","//www.ncbi.nlm.nih.gov/pubmed/17470916","http://www.pharmexec.com/pharmexec/The-First-Plant-Derived-Vaccine-Approved-for-Chick/ArticleStandard/Article/detail/307471","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1369121","//doi.org/10.1038/sj.embor.7400470","//www.ncbi.nlm.nih.gov/pubmed/15995674","//doi.org/10.1016/j.cimid.2007.11.005","//www.ncbi.nlm.nih.gov/pubmed/18243312","//doi.org/10.1038/80231","//www.ncbi.nlm.nih.gov/pubmed/11017040","http://www.fda.gov/AnimalVeterinary/NewsEvents/FDAVeterinarianNewsletter/ucm190728.htm","http://news.bbc.co.uk/1/hi/sci/tech/5041298.stm","https://www.nytimes.com/2009/02/07/business/07goatdrug.html?pagewanted=all&_r=0","http://docs.law.gwu.edu/facweb/claw/MayoPro.pdf","//doi.org/10.1111/j.1467-7652.2010.00552.x","//www.ncbi.nlm.nih.gov/pubmed/20723134","http://www.bioprocessingjournal.com/index.php/article-downloads/329-j22-advantages-of-therapeutic-protein-production-in-the-aquatic-plant-lemna","//doi.org/10.12665/j22.gasdaska","//doi.org/10.1111/j.1467-7652.2005.00127.x","//www.ncbi.nlm.nih.gov/pubmed/17129315","//doi.org/10.1038/nbt1260","//www.ncbi.nlm.nih.gov/pubmed/17128273","//doi.org/10.1007/s00449-007-0151-y","//www.ncbi.nlm.nih.gov/pubmed/17701058","http://protalix.com/procellex-platform/overview-procellex-platform.asp","https://web.archive.org/web/20121027101102/http://protalix.com/procellex-platform/overview-procellex-platform.asp","http://www.globes.co.il/serveen/globes/docview.asp?did=1000745325&fid=1725","https://web.archive.org/web/20130529030847/http://www.globes.co.il/serveen/globes/docview.asp?did=1000745325&fid=1725","https://web.archive.org/web/20110718203226/http://www.bio-pro.de/magazin/thema/00178/index.html?lang=en","http://www.bio-pro.de/magazin/thema/00178/index.html?lang=en","https://www.wired.com/medtech/health/news/2001/11/48108","http://www.molecularfarming.com/about.html","http://www.dowagro.com/animalhealth/resources/news/20060131b.htm","http://www.ea-aw.de/fileadmin/downloads/Graue_Reihe/GR_43_Pharming_062007.pdf","http://www.labtimes.org/labtimes/issues/lt2012/lt04/lt_2012_04_38_40.pdf","http://www.ime.fraunhofer.de/en/about_us.html","http://www.pharma-planta.net/index.php?pg=58","http://www.pharma-planta.net/index.php?pg=61","http://www.gtc-bio.com/","http://www.icongenetics.com/html/5948.htm","http://www.icongenetics.com/html/5954.htm","http://www.bigmap.iastate.edu/images/BIGMAP%20newsletter%20spring06.pdf","http://www.aphis.usda.gov/brs/aphisdocs/08_057109r_nds.pdf","http://psychcentral.com/news/archives/2006-06/isu-isp062306.html","http://www.kbpllc.com/Home.aspx","http://www.biopharminternational.com/biopharm/Upstream+Processing/Plants-As-an-Innovative-and-Accelerated-Vaccine-Ma/ArticleStandard/Article/detail/718082","http://www.medicago.com/English/Technologies/Why-Plants/Alfalfa/default.aspx","https://web.archive.org/web/20121001022426/http://www.medicago.com/English/Technologies/Why-Plants/Alfalfa/default.aspx","http://www.pharming.com/","http://www.in-pharmatechnologist.com/Processing/Pharming-buys-up-PPL-s-patent-estate","http://www.phytonbiotech.com/index-2.html","http://www.planetbiotechnology.com/","http://www.plantformcorp.com/","https://web.archive.org/web/20090108160917/http://www.seedquest.com/News/releases/2003/august/6457.htm","http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=33330","http://www.stineseed.com/about-stine/media/company-leadership/harry-h-stine/","http://tsdr.uspto.gov/#caseNumber=78179017&caseType=SERIAL_NO&searchType=statusSearchUSPTO","http://www.biopharminternational.com/biopharm/Quality/Characterization-of-TrypZean-a-Plant-Based-Alterna/ArticleStandard/Article/detail/742608","http://www.sigmaaldrich.com/life-science/metabolomics/enzyme-explorer/analytical-enzymes/trypzean.html","http://www.goldenrice.org/Content3-Why/why3_FAQ.php#Syngenta","https://sols.asu.edu/people/charles-arntzen","//doi.org/10.1038/news050214-2","http://www.aphis.usda.gov/brs/aphisdocs/10_047102r_nds.pdf","http://www.officeofresearch.wsu.edu/mps/researchers/vonwettstein.aspx","http://www.molecularfarming.org/","http://www.ft.com/cms/s/0/3925a80e-1e32-11e4-bb68-00144feabdc0.html#axzz39ok7ETQX","https://www.bloomberg.com/news/2014-08-05/ebola-drug-made-from-tobacco-plant-saves-u-s-aid-workers.html","http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2009109054","http://www.gpo.gov/fdsys/pkg/CHRG-109hhrg23179/pdf/CHRG-109hhrg23179.pdf","http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=5863309","http://www.in-pharmatechnologist.com/Ingredients/Plant-production-for-cancer-protein","http://www.prnewswire.com/news-releases/tanox-to-acquire-antibodies-from-sunol-molecular-corp-for-potential-treatment-of-inflammatory-disease-cancer-54351832.html","http://contracts.onecle.com/tanox/sunol.apa.2005.03.25.shtml","http://www.businesswire.com/news/home/20080212005194/en/Altor-BioScience-In-Licenses-Tissue-Factor-Antagonists-Genentech","http://altorbioscience.com/team.html","https://www.clinicaltrials.gov/show/NCT00879606","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2927860","//doi.org/10.1160/TH09-06-0400","//www.ncbi.nlm.nih.gov/pubmed/20062929","https://www.theguardian.com/science/2001/sep/09/gm.food","http://www.trelys.com/news050604.aspx","http://sacramento.bizjournals.com/sacramento/stories/2006/01/16/story1.html","http://www.businesswire.com/news/home/20040304005618/en/Large-Scale-Biology-Corporation-Announces-Biomanufacturing-Commercial","http://www.sigmaaldrich.com/catalog/product/sigma/a6103?lang=en&region=US","http://www.pharmaclient.net/biotech/memories.php","http://cordis.europa.eu/fetch?CALLER=EN_PARTNERS&ACTION=D&DOC=432&CAT=PART&QUERY=012c1391b59f:da0f:58589b33&RCN=73876","http://www.aphis.usda.gov/brs/aphisdocs/06_335101r_nds.pdf","http://www.affitech.com/about-us/management-team/sergej-m-kiprijanov","http://www.bizjournals.com/pittsburgh/stories/2003/04/07/daily30.html?page=all","http://www.newswire.ca/en/story/975453/sembiosys-announces-first-quarter-results-and-provides-update-on-activities","http://www.aphis.usda.gov/publications/biotechnology/content/printable_version/BRS_FS_pharmaceutical_02-06.pdf","http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=6741964","http://www.aphis.usda.gov/brs/ph_permits.html","http://www.molecularfarming.com/","https://web.archive.org/web/20110718202735/http://www.bio-pro.de/magazin/umfeld/archiv_2005/index.html?lang=en&artikelid=/artikel/03016/index.html","http://www.gmo-safety.eu/topic/256?mode=doc","https://web.archive.org/web/20050404083632/http://gslc.genetics.utah.edu/features/pharming/","http://www.pewtrusts.org/our_work_report_detail.aspx?id=35424","http://www.aphis.usda.gov/brs/index.html","http://www.epa.gov/biotech_rule/index.htm","http://www.cfsan.fda.gov/~lrd/biotechm.html","https://web.archive.org/web/20060409171359/http://usbiotechreg.nbii.gov/","http://www.aphis.usda.gov/brs/pdf/Pharma_Guidance.pdf","http://www.plantpharma.org","https://www.nsf.gov/od/lpa/nsf50/nsfoutreach/htm/n50_z2/pages_z3/25_pg.htm","http://www.pharma-planta.org","http://www.bio.org/","http://cpmp2005.org/"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Pharming_(genetics)","byteoffset":2444,"anchor":"History"},{"toclevel":1,"level":"2","line":"In mammals","number":"2","index":"2","fromtitle":"Pharming_(genetics)","byteoffset":8978,"anchor":"In_mammals"},{"toclevel":2,"level":"3","line":"Historical development","number":"2.1","index":"3","fromtitle":"Pharming_(genetics)","byteoffset":8994,"anchor":"Historical_development"},{"toclevel":2,"level":"3","line":"Patentability issues","number":"2.2","index":"4","fromtitle":"Pharming_(genetics)","byteoffset":11325,"anchor":"Patentability_issues"},{"toclevel":1,"level":"2","line":"In plants","number":"3","index":"5","fromtitle":"Pharming_(genetics)","byteoffset":14835,"anchor":"In_plants"},{"toclevel":1,"level":"2","line":"Regulation","number":"4","index":"6","fromtitle":"Pharming_(genetics)","byteoffset":19844,"anchor":"Regulation"},{"toclevel":1,"level":"2","line":"Controversy","number":"5","index":"7","fromtitle":"Pharming_(genetics)","byteoffset":20530,"anchor":"Controversy"},{"toclevel":2,"level":"3","line":"Advantages","number":"5.1","index":"8","fromtitle":"Pharming_(genetics)","byteoffset":20918,"anchor":"Advantages"},{"toclevel":2,"level":"3","line":"Disadvantages","number":"5.2","index":"9","fromtitle":"Pharming_(genetics)","byteoffset":23164,"anchor":"Disadvantages"},{"toclevel":1,"level":"2","line":"List of originators (companies and universities), research projects and products","number":"6","index":"10","fromtitle":"Pharming_(genetics)","byteoffset":25446,"anchor":"List_of_originators_(companies_and_universities),_research_projects_and_products"},{"toclevel":1,"level":"2","line":"See also","number":"7","index":"11","fromtitle":"Pharming_(genetics)","byteoffset":42248,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"12","fromtitle":"Pharming_(genetics)","byteoffset":42413,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"9","index":"13","fromtitle":"Pharming_(genetics)","byteoffset":42449,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"10","index":"14","fromtitle":"Pharming_(genetics)","byteoffset":43505,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Pharming (genetics)","iwlinks":[],"properties":[{"name":"defaultsort","*":"Pharming (Genetics)"},{"name":"wikibase_item","*":"Q1142427"}]}}